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ABSTRACT 
Progressive restriction of neural stem and progenitor cell fates in the 
cortex has been linked to a clearly defined sequence of transcription factors that 
regulate neurogenesis and gliogenesis in the developing cortex. In recent years, 
increasing attention has been paid to the epigenetic regulatory mechanisms 
contributing to cell fate choice, largely focusing on intrinsic properties of the 
neural stem cells (NSCs), themselves, rather than microenvironmental influences 
such as vascular investment. To investigate the influence of vascular cells on 
cortical NSC fate choice, we developed a novel coculture system that utilizes 
Transwell® membranes and primary cultures that include an enriched NSC 
population, brain-derived fibroblast/perivascular cells, and brain-derived 
endothelial cells. This porous membrane system allows for investigation of 
juxtacrine, paracrine, and autocrine interactions that influence gene expression to 
direct cell fate. We conducted a transcriptome-wide analysis of altered gene 
expression in the NSCs in response to vascular coculture. Ingenuity pathways 
analysis (IPA®) identified several key pathways that were enriched in the dataset 
including those linked to Leukemia inhibitory factor (Lif) signaling. We observed 
an upregulation of Glial fibrillary acidic protein, Gfap, in NSCs cultured in 
vascular coculture conditions. We used an inhibitor of the Polycomb-repressive 
complex 2 (PRC2) subunit, Ezh2, and quantified differences in Gfap expression 
in NSC derived from E11.5 and E13.5 NSC. These time points bracket a window 
	 xi	
of early forebrain angiogenesis that accompanies rapid proliferation of NSC and 
the expansion of the neuroepithelium. The E11.5 NSC increased Gfap 
expression in response to vascular cell conditioned medium (CM) and Gfap 
levels further increased with Ezh2 inhibition. In contrast, the Ezh2 inhibitor had 
no effect on the response of the E13.5 NSC to vascular cell CM. Our findings 
indicate that vascular investment in the developing cortex can contribute to NSC 
fate decisions via soluble and contact-mediated cell-cell interactions. Further, 
vascular cells may help direct the shift from neurogenesis to gliogenesis during a 
window of NSC sensitivity in early cortex formation.
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CHAPTER I 
INTRODUCTION 
Overview  
All organisms respond to environmental stimuli; however, the enhanced 
ability to process such complex material sets mammals apart from other animal 
classes. This ability is due to the distinct features of the mammalian neocortex 
(Reviewed in [2]). The cortex is a sophisticated organ that allows for the 
integration, analysis, and response to external stimuli. This brain region arises 
from a simple pseudostratified neuroepithelium in the dorsal, anterior forebrain 
and is attributed to higher order functioning such as the formation of complex 
thoughts, coordination of somatosensory input, the initiation of movement, and 
the use of language. Cortical development is a complex process that requires 
multiple cell types to come together and interact within the cellular 
microenvironment to form the complex, six-layered cortex [3-7].  
Neural stem cells (NSCs) are the foundation of the brain and are 
multipotent, meaning they are not only able to self renew, but can also 
differentiate into the other cell types of the brain: neurons and glia (including 
astrocytes, oligodendrocytes, ependymal cells). Each of these cell types have 
their own role in the central nervous system and are involved in its formation and 
function. Neurons are formed during a period known as neurogenesis and are 
responsible for signal transmission and include sensory neurons, motor neurons, 
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and interneurons. The majority of glia formation occurs after neurogenesis in a 
period known as gliogenesis. Traditionally, glia were considered to provide a 
supportive role in the nervous system, although more recent data suggest an 
active role in regulating brain homeostasis among other functions (Reviewed in 
[8, 9]). Astrocytes aid in blood flow, synapse function and the formation of the 
blood-brain barrier (Reviewed in [10-12]) and oligodendrocytes form a myelin 
sheath around neurons that acts to increase action potential conduction 
(Reviewed in [13]). In the adult brain, ependymal cells contribute to the synthesis 
of cerebral spinal fluid and the maintenance of cortical homeostasis (Reviewed in 
[14]). Even though the formation of neurons and glia are temporally restricted, 
their interactions both during development and in the adult brain are needed for 
proper brain functions. For example, astrocytes and oligodendrocytes interact 
with neurons to aid in synapse function and action potential conduction (reviewed 
in [11]). Perturbation of either formation, and function of neurons and glia, or their 
interactions can lead to developmental or pathological disease states. 
One area for which there is a gap in knowledge in the field of cortical 
development involves the molecular and environmental regulators that control 
how the individual cell types are specified and interact during development. 
Previous research in this area has focused on Delta-Notch in mediating cell-cell 
signaling [15] as well as soluble signaling factors such as Wingless (Wnt) [16, 
17], the interleukin-6 (IL-6) cytokine family [18, 19], and Sonic hedgehog (Shh) 
[20, 21] on gene expression changes. The Delta-Notch and Wnt pathways have 
each been implicated in regulating the transition from neural progenitor 
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populations to neurons [15-17] whereas the IL-6 cytokines [18, 19] and Shh [20, 
21] have been implicated in the differentiation of astrocytes and 
oligodendrocytes, respectively.  
To better understand how cells in the developing cortex respond to 
signaling molecules in the microenvironment, research has turned to the role of 
epigenetic regulation. The classical definition of epigenetic regulation is: heritable 
changes in gene expression that do not alter the DNA sequence. DNA 
methylation, where there is an addition of a methyl group to cytosine at carbon-5, 
has been studied extensively in the context of NSC fate restriction as NSCs 
differentiate down neural or glial lineages (Reviewed in [22]). Recently, with the 
advent of new molecular tools, researchers have been able to investigate the role 
of chromatin modifications in relation to NSC differentiation to determine how 
NSCs responsiveness to environmental regulators may be altered intrinsically 
(Reviewed in [23]). These changes in gene expression are regulated via histone-
based modifications and included methylation, acetylation, phosphorylation, and 
ubiquitination, all of which affect availability of chromatin to transcription 
machinery (Reviewed in[24]).  
Of particular interest is the methylation of Histone H3 on lysine 27, which 
generally acts as a transcriptionally repressive histone “mark”. This methylation 
modification is catalyzed by the methyltransferase function of Ezh2 of the 
Polycomb repressive complex 2 (PRC2) and has been implicated in gene 
silencing [25]. The PRC2 subunits have been shown to be expressed in early 
mouse and human cortex development [26] and Ezh2 expression is 
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downregulated as development progresses in mouse cortex [27]. Genetic 
recombination studies with targeted temporal and lineage-specific loss of PRC2 
components have revealed an important contribution for PRC2 and the 
H3K27me modification with regard to restrictive cell fate choices in NSC 
differentiation. Indeed, the timing and balance between NSCs relative to the 
differentiated neurons and glia [27] early on in development and during the 
transition from neurogenesis and gliogenesis at later time points [28] in the 
primitive cortex is significantly altered when PRC2 action is reduced. Chromatin-
based modifications such as H3K27me3 are important to understand how the 
transcriptome of NSCs is rapidly and coordinately changed in response to 
environmental signals resulting in the specification of the various cell types in the 
brain. 
 
Mammalian Cortical Development 
Neurogenesis 
The brain develops from caudal to rostral and ventral to dorsal, with the 
development of the dorsal, anterior forebrain occurring later than other regions 
[29]. Early in development, neuroepithelial cells line and proliferate in the 
ventricular zone and undergo symmetrical division, in which one neuroepithelial 
cell divides and gives rise to two neuroepithelial cells that express Paired box 
protein, Pax6 (Pax6) [30] and Nestin (Nes) [31-33]. In the developing mouse, this 
process occurs around embryonic day (E)9.5-10. NECs are multipotent, meaning 
they are able to form all neural cell types within the brain, some will go on to 
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produce daughter cells that initiate differentiation and migrate towards the pial 
surface to form the different cell types and distinct layers of the mammalian 
cortex [34, 35].  
The migration patterns of newborn neurons ultimately form the six layers 
of the adult brain that consist of functionally linked groups of cells. The first 
neurons born are Cajal-Retzius cells and make up a region known as the 
preplate, located between the pia and the ventricular zone [36]. At E10.5, as 
neurogenesis begins, the preplate separates to form the marginal zone 
(presumptive layer I) and the subplate (presumptive layer VI) as cells from the 
ventricular zone migrate between the two to make up the cortical plate 
(presumptive layers II-V) [37]. As the newborn neurons migrate into the cortical 
plate and their final destination, they travel past older neurons, forming the layers 
in an inside-out fashion.  
Collectively, these layers in the adult brain are; the molecular layer (I), the 
external granular layer (II), the pyramidal layer (III), the inner granular layer (IV), 
the ganglionic layer (V), and the multiform layer (VI). The multiform layer (VI) lies 
closest to the ventricle and the molecular layer (I) lies closest to the pial surface. 
The classification of the six different layers is largely based on function and 
morphology of neurons occupying that area. The molecular layer (I) contains 
Cajal-Retzius neurons that secrete a glycoprotein called Reelin, which aids in 
neuronal migration out of the subventricular zone [38, 39]. The external granular 
layer (II) and the pyramidal layer (III) contain pyramidal cells, which are generally 
considered excitatory cells that integrate signals from dendritic input from brain 
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regions such as the thalamus, amygdala and hippocampus [40]. The inner 
granular layer (IV) contains spiny stellate cells and inhibitory neurons, which 
relay sensory information to layers II and III [41]. The ganglionic layer (V) and the 
multiform layer (IV) are largely composed of large pyramidal cells and inhibitory 
neurons whose processes connect with different regions throughout the cortex 
and the thalamus [42].   
 
Radial Migration of Neurons 
In mice, neuronal migration is initiated around E11.5 as NECs in the 
subventricular zone undergo asymmetric division, in which one NEC and one 
neural progenitor cell are produced [43]. This neural progenitor, known as a 
radial glial cell (RGC) migrates to the ventricular zone where it forms long 
processes that span the distance between the ventricular and pial surface. RGCs 
express Fucosyltransferase 4 (CD15/ Ssea-1) [44], Brain lipid-binding protein 
(Blbp/Fabp7) [29], and Solute Carrier Family 1 Member 3 (Slc1a3/Glast) [3, 45]. 
RGCs were once thought to only differentiate into cells of glial lineage; however, 
it has since been discovered that they are also multipotent and are competent to 
form both neurons and glia [46-49]}. In fact, in vitro studies have found that there 
may be certain subpopulations of RGCs with a broader potential than previously 
realized, whereby RGCs isolated during neurogenesis differentiate into neurons 
and RGCs isolated during gliogenesis predominantly differentiate into glia [46]. 
RGCs undergo symmetric and asymmetric division to produce more 
RGCs and intermediate progenitor cells (IPCs) that express T-Box Brain2 
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(Tbr2/Eomes) [50, 51]. The radial processes of RGCs act as scaffolding to aid in 
IPC migration towards the pial surface. As IPCs migrate they can also undergo 
symmetric and asymmetric division to ultimately form postmitotic neurons that 
express T-Box Brain 1 (Tbr1) and Beta III Tubulin (Tubb3/TuJI) at E12 [29, 33, 
51-53, 54, Bedogni, 2010 #1784]. 
 
Tangential Migration of Neurons 
 The ventral region of the forebrain, the ganglionic eminence, undergoes a 
similar mode of development in which NECs give rise to progenitor cells that will 
become inhibitory interneurons. As in the dorsal forebrain these progenitor cells 
are also RGCs and express Blbp; however, rather than extending processes 
from the ventricular to pial surface, they travel tangentially, parallel to the 
ventricular surface, and into the cortex [29] (Figure 2). The timing and the 
location in the ganglionic eminence that the cells originate from dictate their 
migration trajectory: cells that originate in the medial ganglionic eminence 
migrate through the intermediate zone around E12.5, whereas those from the 
lateral ganglionic eminence travel through the subventricular zone beginning 
around E14.5 [55, 56]. Both neurogenesis and gliogenesis in the ventral forebrain 
occur prior to that of the dorsal forebrain, with gliogenesis beginning as early as 
E14.5. 
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Figure 1: Expansion of the neuroepithelium in the embryonic mouse cortex. 
In the embryonic mouse, pre-natal development is complete within 18.5 days. 
During that time, the cortex undergoes a period of rapid expansion in which 
neuroepithelial cells located in the ventricular zone differentiate into the diverse 
cell types of the brain. Radial glia cells (RGCs) appear around E11.5 and extend 
their processes to the pial surface. Cajal Retzius cells, which make up the 
marginal zone (presumptive layer 1), appear soon after RGCs and are the 
hallmark of neurogenesis. The differentiation of Tbr2+ intermediate progenitor 
cells and Tbr1+ post-mitotic neurons occurs around E12 and E14 respectively. 
These cells occupy the subventricular and intermediate zones. Glial cells begin 
to form in earnest around E14.5 in a period of gliogenesis that continues through 
early postnatal development.  
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Figure 2: Tangential migration of inhibitory neurons from the ganglionic 
eminence (GE). A schematic of one half of a coronal section through a mid-
gestation cortex (E13.5) is shown. The diagram is oriented such that the ventral 
(V) portion is on the bottom, dorsal (D) on the top, the external lateral (L) is on 
the left, and the midline (M) is on the right. Inhibitory neurons migrate from the 
medial ganglionic eminence (MGE, blue) and the lateral ganglionic eminence 
(LGE, red) and travel ventral to dorsal. Neurons from the MGE travel below the 
medial zone (MZ) through the intermediate zone whereas neurons from the LGE 
travel above the ventricular zone (VZ) through the subventricular zone. Along 
with the radially migrating neurons (not depicted), these tangentially migrating 
neurons contribute to the six cortical layers. 
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Gliogenesis 
In addition to generating neurons, the multipotent RGCs also generate 
glia, including astrocytes, oligodendrocytes, and ependymal cells [46, 48, 49]. 
While ependymal cells are important in adult cortical homeostasis (Reviewed in 
[14]), this thesis will focus on the astrocytes and oligodendrocytes. The 
development of astrocytes and oligodendrocytes occurs later in gestation, 
primarily beginning after E14.5 with production occurring in earnest at E17 and 
continuing through early postnatal development in the mouse. RGCs undergo 
transformation in which their endfeet retract from the ventricular surface in order 
to differentiate into astrocytes [49, 57] and oligodendrocyte precursors [49]. This 
transformation is initiated by signaling pathways including IL-6 (Reviewed in 
[58]), BMP [59-61], and Shh (Reviewed in [62]).  
Astrocyte differentiation has been seen to occur under the influence of a 
potent member of the IL-6 cytokine signaling family, Leukemia inhibitory factor 
(Lif) (Reviewed in [58]). The binding of Lif to the NSC surface initiates the 
signaling cascade that ultimately activates Signal transducer and activator of 
transcription 3 (Stat3) [63]. Stat3 is then able to enter the nucleus (Reviewed in 
[64]) and bind to the Gfap promoter to activate Gfap expression, and thus, induce 
gliogenesis [63, 65, 66]. NSC and endothelial cell coculture studies have also 
implicated the bone morphogenetic proteins (BMPs) in regulating Gfap 
expression [59-61]. These BMPs are derived from endothelial cells [60, 67] and 
are thought to also interact with Stat3 to induce gliogenesis [68]. However, 
research has also indicated that these two signaling pathways result in different 
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types of astrocytes, with Lif exposed NSCs responding more like a progenitor cell 
and BMP-exposed NSCs responding more like adult astrocytes [69].  
Much of the research on oligodendrocytes specification and differentiation 
has been done in the spinal cord; however, more recent research has 
emphasized this process in the cortex. Under the influence of Shh signaling, 
oligodendrocyte progenitors develop in the ventral ventricular zone and then 
migrate dorsally to the spinal cord [70, 71]. One signaling pathway that has been 
extensively studied in the development of oligodendrocytes is Shh (Reviewed in 
[62]). Shh signaling has been found to be required for the cortical expression of 
oligodendrocyte marker, O4 [72] and also in the regulation of oligodendrocyte 
progenitor differentiation [73]. Other research has implicated fibroblast growth 
factor (FGF-2) as an independent mechanism in oligodendrocyte progenitor 
development. Using an in vivo model where FGF-2 was injected into E13.5 mice, 
Naruse et al. found that expression of oligodendrocyte progenitor markers 
Oligodendrocyte transcription factor 2 (Olig2) and Platelet-derived growth factor 
receptor A (PDGFR∂) could be detected in the ventricular and intermediate 
zones of the dorsal forebrain [74]. 
 
Cortical Vascularization 
As the cortex expands, the metabolic and oxygen demands of the tissue 
increases, spurring the need for vascular support for the developing tissue. To 
alleviate hypoxic conditions, and under the influence of Vascular endothelial 
growth factor (Vegf), the vasculature is able to remodel to accommodate the 
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demands of the tissue. Blood vessels are made up of endothelial cells and 
perivascular cells (pericytes). Endothelial cells form the vessel lumen and 
pericytes associate with the abluminal surface of the vessel. Pericytes are 
recruited to immature vessels through Platelet-derived growth factor beta (Pdgf-
ß) signaling from the endothelial cells [75] and are found in a 1:1 ratio in the 
developing brain (Reviewed in ([76]). This close association between endothelial 
cells and pericytes acts to stabilize the new structure and maintain vascular 
integrity, especially in relation to the development of the blood brain barrier that 
forms closer to birth (Reviewed in [77]). In addition, direct contact with pericytes 
enables endothelial cell quiescence in mature vessels and alters perivascular 
differentiation to help stabilize the angiogenesis process [78]. 
Quiescent endothelial cells initiate angiogenesis, or vascular remodeling 
of existing vessels, under the influence of Vegf and Notch signaling [79]. These 
cells then undergo a change in morphology to enable migration and are referred 
to as tip and stalk cells [80]. The determination of tip cell versus stalk cell is a 
dynamic process and can change rapidly, but is ultimately related to levels of 
Vegf receptor present on the endothelial cell [81]. The tip cells lead the migration 
towards areas of hypoxia with their long extended processes as the stalk cells 
proliferate to extend the new vessel [79]. These migrating tip cells can then fuse 
to existing vessels or other tip cells to form a vascular network [82]. 
The vasculature in the early telencephalon develops in parallel to the 
expansion of the neuroepithelium [83]. At E9.5, prior to neural differentiation, the 
perineural vascular plexus forms via vasculogenesis in which angioblasts migrate 
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to the head and begin to form a vascular network that surrounds the outer 
surface of the brain [84]. Another vascular plexus, the periventricular plexus, 
forms via angiogenesis as the basal vessel migrates ventral to dorsal and 
develops parallel with the ventricular surface until reaching the medial wall at 
approximately E11 in the mouse (Figure 3A-B). The development of the  
periventricular plexus establishes a route that guides the tangential movement of 
neural precursor cells from the ganglionic eminence to the cortex [85-87]. Under 
the influence of angiogenic signals such as Vegf A, blood vessels from the 
perineural vascular plexus ingress into the expanding neuroepithelium to 
combine with the periventricular plexus around E10 and occur steadily until 
E14.5 [79, 88-92] (Figure 3C). These vascular ingressions accompany the 
increasing metabolic demands of the tissue with the new vessel growth providing 
metabolic and physiological support, as well as a source of regulatory factors, on 
which the NSC may depend for their survival and differentiation [89, 90, 93]. 
 
Cellular microenvironment of the developing cortex 
The microenvironment that NSCs and vascular cells inhabit together is 
known as a neurogenic niche. This niche is present during both embryonic 
cortical development and in the adult brain. Several signaling factors are required 
for recruitment of specific cell types to the neurogenic niche. The endothelial cells 
that comprise the blood vessels secrete Vegf and Pdgf-ß to recruit NSCs and 
pericytes, respectively. In addition, the niche has been shown to be a source of  
 
	 15 
 
Figure 3: Vascularization of the embryonic mouse cortex. 
Illustrations of one half of a coronal section (A) and sagittal section (B) through a 
mid-gestation cortex (E13.5) illustrates cortical vascularization (red arrows) 
proceeding in a ventral-dorsal (V-D), caudal-rostral (C-R) pattern (A and B) with 
the vascularization of dorsal anterior forebrain being vascularized last. Around 
E10, blood vessels from the surrounding perineural vascular plexus begin to 
ingress into the expanding cortex to meet the increasing metabolic demands of 
the growing tissue (C). Later in development, the ingressing blood vessels form 
more elaborate plexi, anastomosing with nearby vessels and establishing critical 
vascular support. 
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spatial cues and cytokines that can promote survival, proliferation, differentiation, 
and quiescence of NSC in the developing forebrain [75, 93-95]. 
The cellular microenvironment has also been implicated in cell movement, 
especially in the case of tangentially migrating neuronal [87] and glial cells [96, 
97]. As these cells move, they form branched processes that lead the way for the 
trailing soma. The formation of these branched axons is guided by 
chemoattractants and chemorepulsants that stimulate both the formation of new 
axons and the angle at which they form that ultimately influencing their final 
destination in the cortex [98-101]. These chemoattractants and chemorepulsants 
include semaphorin ligands and their plexin or neuropilin receptors [102] along 
with the Slit proteins [103] and their Robo receptors [104]. In addition, the 
migration of oliogodendrocyte precursors are influenced by Transforming growth 
factor beta (Tgfß) which originates from the pericytes and is expressed when the 
pericytes are in contact with the endothelial cells [105]. 
 
NSC Fate Determination and Epigenetic Regulation 
One way in which NSCs are able to respond to environmental signals is 
through epigenetic regulation of the transcriptome. Epigenetic regulation allows 
for changes in gene expression without changes to the underlying genetic 
sequence through mechanisms such as DNA methylation and histone-based 
modifications (among others). DNA methylation is the addition of a methyl group 
to cytosine at CpG dinucleotides and can alter the way transcription factors bind 
to DNA. When gene promoters are methylated, transcription factors are blocked 
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from binding to the gene promoter to activate gene transcription. While changes 
in gene activity due to DNA methylation have been demonstrated to play a role in 
NSC differentiation to neural and glial lineages (Reviewed in [22]), the current 
research is largely focused on gene expression changes as a result of histone 
modifications, specifically PRC2-mediated modification to H3K27me3. 
Histone modifications are posttranslational modifications at critical histone 
amino acids, such as serine or lysine, and can include acetylation or methylation 
of the protruding histone tails in the nucleosome [24]. Histone acetylation 
generally acts as a gene activator, remodeling the DNA around the histone such 
that it is more accessible for transcription, whereas methylation often confers a 
transcriptionally repressive mark, although this can vary depending on the 
specific histone amino acid, or combinations of amino acids, that are modified. 
Due to these active and repressive marks, acetylation and methylation have 
been linked to gene expression changes in NSCs that ultimately guide cell fate 
decisions [106]. One histone modification, in particular, histone modification that 
has been extensively researched for its role in gene silencing is H3K27me3, the 
methylation of which is catalyzed by the Ezh2 component of PRC2 [25]. The 
rationale for the involvement of H3K27me3 is that as the NSC transition to a 
more restricted fate, there should be accompanying repression of stem-cell 
associated genes (chromatin regions) as well as repression of lineages separate 
from the ones being generated. In this latter case, the supposition is that as 
gliogenesis ensues, neurogenesis-specific gene expression would be repressed. 
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Polycomb-repressive complex 2 (PRC2) and the developing cortex 
PRC2 is a member of the Polycomb-group protein family and contains four 
core subunits: Embryonic ectoderm development (Eed), Enhancer of zeste 
(Ezh2) and its homolog Ezh1, suppressor of zeste 12 (Suz12) and RbAp46/48 in 
addition to multiple “facultative” (Aebp2, Jarid2, Pcl) subunits that are able to 
assemble with the core subunits (Reviewed in [107]). The Ezh1/2 is responsible 
for the histone methyltransferase function of this complex; it has the ability to 
mono-, di-, and tri-methylate lysine 27 on histone H3 (H3K27me1, H3K27me2, 
and H3K27me3) [25, 108]. In the developing cortex, neural progenitors express 
Ezh2 and the repressive mark H3K27me3; however, both Ezh2 and H3K27me3 
expression decrease with the progression of embryonic development [27]. 
One way to study the role of Ezh2 and H3K27me3 in NSC fate 
determination is through loss of function experiments. When Ezh2 is deleted 
using floxed alleles with Cre recombinase expression driven by the cortex 
specific Emx1 promoter at E9.5, prior to neurogenesis onset, there is a decrease 
in H3K27me3 in progenitor cells. There is also a shift in the balance between 
NSC self-renewal, resulting in an increase in neurons early on but a thinner 
cortex at birth with precocious onset of gliogenesis [27]. Hirabayashi et. al also 
studied the effect of Ezh2 deletion using transgenic mouse lines with a nestin 
enhancer element driving an inducible Ezh2 recombinase knockout at E13.5 and 
E14.5. They found that there was an increase of genes normally expressed 
during neurogenesis with a decrease in gliogenesis genes at P1.5 ([28]). These 
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results suggest the involvement of PRC2 through H3K27me3 via Ezh2 in NSC 
fate determination in the cortex with significant consequences for gliogenesis. 
 
Hypothesis and rationale for study 
This thesis research aims to integrate neural stem cell differentiation and 
cortical vascularization and is designed to explore how NSCs respond to 
vascular microenvironmental cues via epigenetic mechanisms as they undergo 
differentiation during early development. Specifically we want to understand if 
NSC fate choice is intrinsic or if there are extrinsic cues produced by the vascular 
microenvironment that alter gene expression. If the vasculature does provide 
microenvironmental cues, we want to explore by what mechanism it operates 
and want to look at how epigenetics may be regulating cell transitions. 
Furthermore, we will explore the role of the Polycomb repressive complex 2 
(PRC2) in modifying the epigenetic landscape in neural stem cells (NSCs), 
particularly the PRC2-mediated trimethylation of histone H3. Our hypothesis is 
that the vascular cells direct NSC fate during cortical angiogenesis through 
factors released by the vasculature that modify the epigenetic landscape in the 
NSC.  
This thesis work will result in the development of a model system that is 
able to recapitulate the developing cortical microenvironment to analyze NSC 
gene transcription as a result of different signaling paradigms (autocrine, 
juxtacrine, and paracrine). Many cortical malformations, such as cephalic 
disorders (Reviewed in [109]) and epilepsy (Reviewed in [110]) arise due to 
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improper cortical layer formation and recent research has looked to the impact of 
vasculature on disease onset or progression [111]. Therefore, our results may 
help us to understand some of the neurodevelopmental anomalies that may arise 
as a result of disrupted cell-cell communication and altered cell fate decisions.  
  
	 21 
CHAPTER II 
METHODS 
Animal Husbandry and Timed Pregnancies 
This study utilized C57 Black 6 (C57B16) mice. Mice were housed in a 
temperature-humidity controlled room with 12-hour (hr) light/dark cycles. 
Handling and euthanasia were performed according to NIH guidelines and were 
approved by the University of North Dakota Institutional Animal Care and Use 
Committee (IACUC protocol #1806-5C and Animal Welfare Assurance #A3917-
01). Timed pregnancies were used to collect embryonic (E)11.5 and 13.5 mice 
embryos. Plug date was designated as E0.5 and developmental time points prior 
to dissection were confirmed by weight gain.  
 
Cell Culture  
Embryo Collection. Embryos were dissected from the dual uterine horns at E11.5 
and E13.5. After dissection, the embryos were transferred to a petri dish 
containing Dulbecco’s phosphate buffered saline (PBS; MilliporeSigma, 
Burlington, MA) solution without calcium (Ca+2) and magnesium (Mg+2) and with 
penicillin-streptomycin (Pen, 100 U/ml and Strep, 100µg/ml), Gibco®, Grand 
Island, NY). The developmental time point was confirmed for each individual
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embryo based off of regional anatomical markers prior to further dissection, 
largely focused on the structure of the fore- and hindlimbs, the eye development 
major sulci divisions of the developing mid- and forebrain, and the whiskers (see 
Figure 4 for anatomical reference points). 
 
Neural Stem Cells. NSCs were collected via microdissection of E11.5 and E13.5 
forebrain regions as shown (Figure 4). The tissue was manually dissociated via 
gentle pipetting in StemPro® Accutase® (Gibco®) and then incubated for 10 
minutes at 37˚C with periodic agitation. After incubation, cells were again 
manually dissociated until they formed a single cell suspension, washed with 
Complete Neurobasal (NB) medium [NB medium (Gibco®), supplemented with 
B27 (Gibco®), N2 (Gibco®), Pen Strep (100 U/mL, Gibco®)] and were then plated 
on a 12-well plate. To enrich for NSCs in the mixed population, NSC cell surface 
marker Ssea-1 [44, 112] was used in conjunction with magnetic bead isolation 
(Dynabeads™, Invitrogen, Carlsbad, CA). Magnetic beads conjugated to IgM 
were pre-cleared by washing 75 µl bead slurry twice with wash buffer containing 
PBS with Ca2+ and Mg2+ and 0.1% BSA. Pre-cleared beads were then incubated 
with 10 µl SSEA-1 IgM antibody (5 µg; BD-Pharmingen™, San Jose, CA) for 30 
min at 4˚C with gentle rocking. Antibody bound beads were washed three times 
to remove residual antibody prior to incubation with cells. Cells were incubated 
with antibody bound beads for 20 min at 4˚C with gentle rocking. Unbound cells 
were discarded and bound beads were washed twice before elution with 
complete NB medium with 100 ng/ml recombinant mouse Epidermal growth  
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  Figure 4: Schematic illustrating 
differences in morphological 
development at embryonic time 
points from E11.5- E14.5. Embryos 
are dissected from the dual uterine 
horns at E11.5 and E13.5. The 
embryonic time point can be 
determined from 6 features including 
the formation of hind limb (1) and fore 
limb (2) digits, whiskers (3) and the 
forebrain-midbrain sulci (4) and the 
midbrain-hindbrain sulci (5). The red 
outlines illustrate the dorsal anterior 
forebrain, this is the region that gives 
rise to the cortex and is the source of 
the NSC populations for our cultures. 
Adapted from “The Atlas of Moue 
Development” by M.H. Kaufman[1].	
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factor (Egf, Gibco®). To enrich for the formation of neurospheres, non-adherent 
cells were collected and moved to new wells during splits. NSC populations were  
maintained for 4-6 weeks in an In-VitroCell incubator (Nuaire, Plymouth, MN) at 
37˚C, 5% CO2 and 95% humidity. 
 
Vascular cells. Primary cultures of mouse brain-derived vascular endothelial cells 
(BMEC) and mouse brain-derived vascular fibroblast (BMFb) cells were obtained 
from CD1 adult mouse brain (Cell Biologics, Chicago, IL) and maintained in 
complete Dulbecco’s Modification of Eagle’s Medium (DMEM) with Glutamax and 
4.5 g/L glucose (Gibco®) supplemented with 15% heat-inactivated fetal bovine 
serum (Gibco®), penicillin solution (100 U/ml), and streptomycin (100 µg/ml). 
BMECs were plated on gelatin-coated flasks using the manufacturer’s 
recommended coating solution (Gelatin-Based Coating 0.2% Solution, Cell 
Biologics). After a 15-minute (min) incubation at 37˚C in the coating solution, the 
plates were washed one time with complete DMEM and the cells were added 
without allowing the flasks to dry. The BMFb were maintained in the same 
medium with the coating paradigm similar to that for the endothelial cells. BMECs 
and BMFbs were maintained for up to 3-4 passages in the same incubator 
conditions as the NSCs. 
 
Heterotypic Cell Culture using Transwells®. Six-well Transwells® (0.4 µm pore 
size; 4.67 cm2, Corning Incorporated Life Sciences, Corning, NY) were used to 
establish heterotypic culture conditions in which the underside of the membranes 
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were coated with gelatin (Cell Biologics). Cell counts for assay plating were 
determined by counting a diluted suspension of cells that had been stained with 
0.4% Trypan blue stain (10 ul cell suspension plus 10 ul Trypan blue; 
NanoEnTek, Waltham, MA) with an EVE™ automated cell counter (NanoEnTek). 
A total of 100,000 BMEC and BMFb cells were plated in a 1:1 density on either 
the bottom of the membrane in contacting conditions or the bottom of the lower 
compartment in non-contacting conditions (see Figure 8 for cell set up). The 
minimal pore sized allowed process contact, but not cell migration across the 
membrane. The vascular cells were incubated for a minimum of 1 hr to allow the 
cells to adhere, after which, the media and non-adherent cells were removed by 
vacuum. The vascular cells were allowed to grow for up to one day in complete 
DMEM medium to allow for uniform establishment of both cell types and were 
washed with complete NB media prior to the addition of 50,000 NSCs to upper 
compartment of the Transwell® inserts. Cells remained in coculture for five days 
with complete NB medium with 20 ng/ml Egf.  
 
Conditioned medium with Ezh2 inhibitor. To recapitulate diffusible vascular 
signals from the developing blood vessels we used vascular cell conditioned 
medium (CM) from BMECs and BMFbs that was generated by plating the two 
populations together (1:1) on a plastic petri dish. They were cultured in the basic 
assay medium for coculture, complete NB medium with 20 ng/ml Egf for five 
days. Upon the fifth day, the media was collected, centrifuged to remove large 
debris, and then filtered (0.22 µm) to remove smaller cell debris. To replenish 
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nutrients that the vascular cells may have depleted over the five days, 50% 
complete NB media with 20 ng/ml Egf was added to the CM prior to use in 
conditioned medium assays. Neurospheres were disrupted through incubation 
with StemPro® Accutase® (Gibco®) at 37˚C for 10 min and were resuspended and 
plated as a single cell suspension in 0.5 ml complete NB with 20 ng/ml Egf on 
day 0.  
To test the role of PRC2 in relation to the effect of vascular signals on 
NSCs, an Ezh2 inhibitor, EI1 was used. Based on published work [113] and on 
preliminary viability tests in our lab, the concentration of 10 µM was used. On day 
1, the cells begin their treatment period and are cultured in four conditions: NB 
(20 ng/ml EGF), NB with EI1 (20 ng/ml EGF, 10 µM EI1), CM (20 ng/ml EGF), 
CM with EI1 (20 ng/ml EGF, 10 µM EI1). To avoid disruption of the cells, the 
addition of the treatment conditions were applied as a volume 0.5 ml to the 
original 0.5 ml NB media, thus the concentration of EI1 was 20 µM such that the 
final concentration was diluted to 10 µM. Additional media was added to each 
condition on day 3 and the experiment was collected for either RNA or protein 
extraction on day 5. 
 
RNA Isolation and Quantification 
Total RNA was extracted from NSCs in solo and in coculture. Prior to collecting 
NSCs, membrane bottoms were wiped off with a Kimwipe. Cells were collected 
by gentle scraping in media from transwell® membranes and were washed with 1 
mL PBS and centrifuged in a 1.5 mL eppendorf tube at 1500 rpm for 3 min. 
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Supernatant was removed and the Arcturus® PicoPur® RNA Isolation Kit (Thermo 
Fisher Scientific/Applied Biosystems, Waltham, MA) was used to extract total 
RNA. A total of 50 or 100 µl extraction buffer was used to lyse cells prior to 
column purification depending on cell pellet size. This was done by incubating 
cells and extraction buffer at 42˚ C for 30 min. An equal volume of 50% ethanol 
was combined with the extraction buffer and was transferred to a pre-conditioned 
purification column. The purification column was washed with Wash Buffer I 
followed by a 15 min on-column DNase I digestion (Qiagen, 3 Kunitz units per 
column isolation) to remove genomic DNA. The purification column was washed 
two more times with Wash Buffer II and RNA was eluted in nuclease-free water 
(Ambion™, Thermo Fisher Scientific) for sequencing applications or in elution 
buffer for cDNA synthesis. Total RNA was quantified using the Nanodrop DS-11 
Spectrophotometer (DeNovix Wilmington, DE), and sample quality ensured with 
A260/280 ratios between 1.8 and 2.0.  
 
RNA-Seq and Transcriptome Analysis 
Library preparation and high throughput sequencing were performed by 
Novogene (California, USA) using the HiSeq 4000 system to generate 150 bp, 
paired-end reads. RNA integrity (RIN) was assessed with an average of 8.9 for 
the samples. Sequence data generated by Novogene were initially trimmed and 
aligned with the help of the Epigenetics Bioinformatics Core (funded by the 
Epigenetics COBRE Phase I grant). Initial quality control of the sequencing data 
was performed using FastQC. There were a total of 53-72 million clean reads 
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generated per sample which were aligned to mm10 reference genome (UCSC) 
using hisat2. Counts were calculated with the featureCounts tool in the RSubread 
package (Bioconductor) according to the RNA-Seq workflow established by the 
Bioinformatics Core. The DESeq2 package [114] (Bioconductor) was used to 
generate the dispersion plot for the data, to conduct the principle components 
analysis (PCA) and group clustering, and differential expression statistics. 
Criteria for significance was determined based on a false discovery rate (FDR) of 
0.05 and a base mean count greater than 100.  
 
cDNA Synthesis  
cDNA was generated via reverse transcription of 400ng of total RNA using the 
GeneAmp RNA PCR Core Kit (Thermo Fisher Scientific/Applied Biosystems). 
Total RNA was incubated with Moloney Murine Leukemia Virus (M-MuLV)-derived 
Reverse Transcriptase (200 U/µl), RNase Inhibitor (20 U/µl), Buffer RT (500 mM 
KCL and 100 mM Tris-HCl), MgCl2 (25 mM), Random Hexamers (400 mM), Oligo 
d(T) (50 µM), dATP (100 mM), dTTP (100 mM), dGTP (100 mM), dCTP (100 mM), 
and nuclease-free water in a C1000 Touch™ Thermal Cycler (BioRad Laboratories, 
Hercules, CA) at 42oC for 15 min followed by 5 min at 99˚C. The cDNA was 
amplified with 18S or glyceraldehde phosphate dehydrogenase (Gapdh) primers 
prior to downstream use.  
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Quantitative Real Time PCR (qPCR) 
Primer design and amplicon subcloning for standard curve. Primers were 
designed using the Integrated DNA Technologies and NCBI Primer-Blast online 
software. Oligo calculator was used to analyze GC content and melting 
temperature. Primers were designed to have a GC content around 50% and a 
melting temperature between 50 and 60˚C. Standard PCR was used to 
determine if the primers were able to amplify the correct gene product using 
cDNA from embryonic mice at various timepoints in development. For the PCR 
reaction, 0.5 µl of cDNA was combined with 0.2 µm forward and reverse primers, 
and 9 µl Platinum PCR Supermix (Invitrogen) and was then amplified using 
standard PCR cycling: 95˚C, 5 min [(98˚C, 30 sec; 98˚C, 45 sec 53-58˚C, 30 sec; 
72˚C, 45 sec X 29); 4˚C, ∞]. Primer sequences and annealing temperatures are 
provided in Table 1 in the Appendix. PCR products were then run on a 1.2% 
agarose (Thermo Fisher Scientific/Fisher Bioreagents) gel against a 100bp DNA 
ladder (Invitrogen) and visualized at 650nm. The product size was then 
compared to the DNA ladder to determine if it matched the gene of interest and 
sequence confirmed to ensure that the primers amplified the correct product as 
we have previously described [89, 90].  
 Products that matched the gene of interest were subcloned using the 
TOPO™ TA Cloning™ Kit (Thermo Fisher Scientific/Invitrogen). The TOPO-TA 
vector is double stranded with 3’ thymidine overhangs which complement the 3’ 
adenine overhangs of the PCR product. The product was ligated into the vector 
by combining 2 µl PCR product, 1 µl salt solution, 2.5 µl water, and 0.5 µl TOPO-
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TA vector and incubating for 5 min at room temperature. The recombinant vector 
was transformed into TOP10 chemically competent E. coli via heat shock. A total 
of 2 µl recombinant vector was added to 25 µl TOP10 E. coli which was 
incubated on ice for 5 min, transferred to 42˚C for 30 sec, followed by a second 
incubation on ice for up to 5 min. After heat shock, the E. coli were allowed to 
recover in Super Optimal Broth with catabolic repression medium for 1 hr with 
gentle shaking at 37˚C. They were then spread across an agar plate, which was 
made by dissolving a tablet of Luria Broth (LB) agar (MilliporeSigma) into 500 mL 
of sterile water and autoclaving to remove contaminants. Once the LB agar had 
cooled, 100 µg/mL ampicillin was added and then poured into petri dishes. After 
the E. coli were spread across the agar plates, they were incubated overnight at 
37˚C.  
 
Plasmid purification. Colonies were chosen from the agar plate after the 
overnight incubation at 37˚C. A single colony was added to a tube containing LB 
agar and 100 µg/mL ampicillin and incubated overnight at 37˚C with gentle 
shaking. The next day 1 mL of each liquid culture was centrifuged at 8000 x g for 
3 min. The supernatant was discarded and the pellet was resuspended in 1X 
lysis buffer (Zyppy™ Kit, Zymo Research, Irvine, CA) by inversion. The lysis was 
then inactivated by adding cold neutralization buffer was centrifuged at 11,000 x 
g for 3 min. To retrieve the plasmid, the supernatant (which contains the plasmid) 
was transferred to a spin column within a collection tube and centrifuged at 
11,000 x g for 15 sec. The flow-through was discarded and the column washed 
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once with Endo-Wash Buffer and centrifuged for 15 sec at 11,000 x g and then 
washed with Zyppy™ Wash Buffer and centrifuged for 30 sec at 11,000 x g. The 
plasmid was then eluted into a clean 1.5 mL microcentrifuge tube using 50 µl of 
Zyppy™ Elution Buffer and was amplified using Standard PCR with M13 specific 
primers. The amplicon was then size checked on an agarose gel as previously 
described. Amplicons of the appropriate size were amplified using BigDye 
Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific/Life 
Technologies) with M13- specific primers and then sequenced using 3100 
Genetic Analyzer (Thermo Fisher Scientific/Applied Biosystems). The sequences 
were analyzed using BioEdit (Ibis Bioscience, Carlsbad, CA) and confirmed using 
NCBI BLAST. Prior to use in Quantitative real time PCR (qPCR), amplicons were 
ethanol precipitated in which 10 µl of amplicon product was brought up to 200 µl 
with water and then 10% volume of 3M sodium acetate and 2.5X volume of 
100% ethanol was added. The precipitation mixture was vortexed thoroughly and 
incubated overnight at -80˚C followed by centrifugation at 15,000 rpm for 5 min. 
The resulting pellet was washed with cold 70% ethanol and re-centrifuged as 
before. Supernatant was removed and pellets were air dried at room temperature 
and re-suspended in 50 µl TE. Amplicons were quantified (Nanodrop) and at -
20˚C until use in standard curve in qPCR. 
 
Quantitative real time PCR (qPCR). Amplicons specific to each primer pair were 
used to perform a 1:10 serial dilution in TE to generate an 8-point log standard 
curve. The formula of this standard curve (y=mx+b) was used to determine the 
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concentration of gene transcripts of unknown samples in various treatment 
conditions as described in [90, 115]. For each qPCR reaction, 5 µl Absolute Blue 
SYBR® Green with ROX (Thermo Fisher Scientific) was combined with forward 
and reverse primers (Appendix, Table 1) and water and then added to a 96-well 
plate. cDNA and standard curve samples were added to the 96-well plate, 
centrifuged at 1000 rpm for 1 min, and then run on a StepOnePlus™ Real-Time 
PCR System (Thermo Fisher Scientific/Applied Biosystems) using the 
preprogramed SYBR Green cycling procedure. Amplicons used for qPCR were 
small ribosomal subunit (18S), glyceraldehyde 3-phosphate dehydrogenase 
(Gapdh), Hypoxanthine-guanine phosphoribosyltransferase (Hprt), Pax6, Tbr2, 
Vimentin, Calbindin 1, Gfap, Cxcr4, Cxcr7, and Cxcl12. Primer amplification 
efficiency was calculated based on the slope of the standard curve as previously 
described [90, 115] using the following formula in excel “=Power(10,-1/slope)-1” 
with 100% primer efficiency based on a slope of -3.3.  
 
Histone Extraction and Modification Enzyme-linked immunosorbent assay 
(ELISA) 
Histones were extracted from NSCs in solo and in vascular co-culture. Cells were 
collected from Transwell™ membranes by gentle scraping in media and 
centrifuged in 1.5 mL eppendorf tubes at 1500 rpm for 3 min. Media was 
removed and the EpiQuik™ Total Histone Extraction Kit (EpiGentek, Farmingdale, 
NY) was used to isolate histones from cell pellets according to manufacturer’s 
instructions. Total protein concentration was determined using a RcDc protein 
concentration assay (Bio-Rad Laboratories, Hercules, CA) relative to a bovine 
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serum albumin (BSA) protein standard curve generated in matching 
extraction/lysis buffer. Pre-lysis extracted proteins and histone extraction 
insoluble proteins were retained separately for downstream applications.  
The EpiQuik™ Histone H3 Modification Multiplex Assay Kit was used to 
quantify 21 different histone modifications. This assay contained two controls; 
blank wells and control wells. A total of 50 µl of solution AB was added to the 
blank well and 49 µl solution AB with 1 µl of the control protein (5 and 25 
ng/well). For each of the sample wells, 46-49 µl of solution AB was combined 
with 1-4 µl of histone extract concentrated at 50ng. The 96 wells were then 
covered with adhesive film and incubated at 37˚C for 120 min. After incubation, 
the reaction solution was removed and the wells were washed three times with 
150 µl of the Diluted Wash Buffer solution. To bind antibody, a total of 50 µl 
Diluted DA was added to each well and incubated in the dark at room 
temperature (RT) for 30 min and then washed four times with 150 µl Diluted 
Wash Buffer. A total of 100 µl Developing Solution was added to each well and 
incubated in the dark at RT for 5 min at which time 100 µl Stop Solution was 
added to stop the enzymatic reaction. The plate was read using Gen5 software 
(BioTek Instruments Inc., Highland Park, Vermont) on a BioTek™ Epoch™ 
microplate spectrophotometer (BioTek Instruments Inc.) at wavelengths of 
450nm and 655nm. The following equation was used to calculate H3 
modification, where OD is optical density: 
 !3	$%&'(')*+'%,	 (,.) 0.⁄ 23%+4', = 	 (6789:;	<=>?:7@A	<=)÷CDD	@E(FGG7H	IJ@KLJ:	<=>?:7@A	)<=)÷MN	@E × 1000 
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Protein Extraction and Western Blot Analysis  
NSCs were collected from Transwell™ membranes as previously described and 
300 µl of Radioimmunoprecipitation assay (RIPA) buffer [500mM Tris (pH=8, 
Thermo Fisher Scientific/Fisher Bioreagents), 3M NaCl (Thermo Fisher 
Scientific/Fisher Bioreagents), 100mM DTT, 10%SDS (Thermo Fisher 
Scientific/Fisher Bioreagents), 10% IGEPAL®/NP-40 (MP Biomedicals, Santa 
Ana, CA), 10% Na-deoxycholate (Thermo Fisher Scientific/Fisher Bioreagents), 
1X protease inhibitor cocktail (100X stock, MilliporeSigma)] was added to the cell 
pellet and was incubated on ice for 30 min, vortexing every 10 min. Samples 
were centrifuged at 15,000 g for 20 min at 4˚ C. Supernatant containing soluble 
protein was transferred and stored at -80˚ C. Total protein was determined as 
previously described. Protein was loaded on a 10% SDS-PAGE gel (5% stacking 
gel) and transferred to a Polyvinylidene difluoride (PVDF) membrane 
(Immobilon©, MilliporeSigma). Membranes were blocked in 5% non-fat milk in 
Tris-buffered saline (TBS), washed twice in 1X TBS+Tween and probed with 
primary antibodies: Gfap (abcam®, Cambridge, MA), Tbr2 (abcam®), Id4 
(BioCheck, San Francisco, CA), Blbp (abcam®) and ßeta actin (abcam®/Novus 
Biologicals, Littleton, CO) for 90 min at RT or overnight at 4˚ C. Blots were 
washed twice in TBS+Tween to remove residual antibody and were incubated in 
anti-rabbit or mouse IgG secondary antibody conjugated to alkaline phosphatase 
(Jackson ImmunoResearch Laboratories Incorporated, West Grove, PA). Two 
more TBS+Tween washes were performed followed by two washes in developing 
buffer. Proteins were visualized using chemiluminescence (CDP-Star™, 
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invitrogen) and band density determined using an Odyssey®FC Imaging System 
(LI-COR® Biosciences, Lincoln, NE).  
 
Leukemia inhibitory factor (Lif) ELISA 
Media from the Transwell® coculture experiment was collected, centrifuged, and 
filtered to remove cell debris. A Quantikine® ELISA (R&D Systems®, Inc, 
Minneapolis, MN) for Mouse Lif was used to detect the presence of Lif in 
coculture media. A standard curve was generated via a serial dilution of Mouse 
Lif standard, ranging from 1400 pg/ml to 21.9 pg/ml. A total of 50 µl coculture 
media, positive Lif control, negative media control, and 50 µl standard were 
added to their respective wells on the ELISA plate and incubated for two hrs. at 
RT prior to being washed five times using Wash Buffer (included in kit 
components). A total of 100 µl Mouse Lif Conjugate Buffer (included in kit 
components) was added to each well and incubated for two hrs prior to another 
set of five washes. Another 100 µl of Substrate solution was added to each well 
and incubated in the dark for 30 min at RT after which, 100 µl of Stop Solution 
was added into each well. The ELISA plate was then read using the same 
software and spectrophotometer as before at wavelengths of 450nm and 540nm. 
To determine final concentrations of Lif, the readings 540nm were subtracted 
from the reading at 450nm and then plotted against the standard curve. The 
minimum sensitivity of this ELISA was 10 pg/ml.  
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Immunolabeling 
NSCs from coculture and BMECs and BMFbs were fixed in buffered 4% 
paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA) in PBS, washed 
with PBS and then permeabilized with Block Solution [3% donkey serum 
(Jackson ImmunoResearch), 2% goat serum (Vector Laboratories, Burlingame, 
CA), 0.1% Triton X-100 (Thermo Fisher Scientific/Fisher Bioreagents), and 2% 
BSA in PBS for 1 hr at RT. The sections were incubated with primary antibodies: 
Pax6 (NovusBio), Laminin (MilliporeSigma), Smooth muscle actin (SMA; 
MilliporeSigma), Lectin (Vector Laboratories, San Diego, CA) and Gfap 
(NovusBio) at optimized dilutions for 2 hrs at RT or overnight at 4˚C in a sealed, 
moist chamber. Isotype-matched IgG or absence of primary antibody were used 
as negative controls. For non-directly conjugated primary antibodies, the cells 
were incubated with species matched secondary antibodies conjugated to cy3 or 
fluorescein isothiocyanate (FITC) and DAPI (AnaSpec Incorporated, San Jose, 
CA) for 1hr at RT. Slides were permanently mounted using Vectashield mounting 
medium (Maravai LifeSciences/Vector Laboratories) and imaged using an 
Olympus BX51WI fluorescence microscope at 40X with a MBF CX 9000 camera 
(MBF bioscience, Williston, VT) and Picture Frame software (MBF bioscience). 
Composites were generated using Photoshop CC 2018 (Adobe Systems, San 
Jose, CA). 
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Statistical Analysis 
Assumptions of the ANOVA were verified using R software by plotting the 
residuals of the data using histograms and Q-Q plots and calculating variance. 
All statistical analyses and figure generation were performed using the program 
GraphPad Prism 7 (GraphPad Software, La Jolla, CA). Analysis included both 
one-way and two-way ANOVAs with Tukey’s post hoc and the Kruskal-Wallis test 
with a Dunn’s post hoc. Statistical results and specific p-values are reported in 
the text or figure legends, as appropriate. 
 
Figure Generation  
All schematics used in this body of work were original designs (K.M.) and created 
with Photoshop CC 2018 (Adobe Systems). 
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CHAPTER III 
RESULTS 
Establishment of neuro-vascular in vitro model system 
To study the role of the vasculature in NSC fate determination, NSCs were 
isolated from the dorsal-anterior forebrain of E13.5 mice and subjected to Ssea-1 
magnetic bead enrichment (Figure 5). These NSCs grew into free-floating 
neurospheres. In culture, the neurospheres expressed the stem cell marker Pax6 
(Figure 6). Brain microvascular endothelial cells (BMECs) and fibroblasts 
(BMFbs, perivascular precursors) were purchased from Cell Biologics, grew as a 
single monolayer, and expressed cell type specific markers, G. simplicifolia lectin 
and Smooth muscle actin (SMA), respectively (Figure 7).  
Based on these source populations of NSCs and vascular cells, we 
utilized a Transwell® tri-culture system to model interactions between NSCs and 
vascular cells during early cortical development in vitro (Figure 8). The 
Transwells® are useful because they allow diffusion, but not diapedesis, through 
a porous membrane and provide a model that recapitulates the 
microenvironment of the primitive cortex where NSC fate choices occur in the 
context of a developing vascular plexus. While the lab has previously used 
various combinations of cell populations in the Transwells® system, the 
conditions had to be optimized for the non-adherent neurospheres and the brain-
derived vascular cells that had not been previously combined. In this way, NSCs  
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Figure 5: Isolation of Ssea-1 positive NSCs using magnetic bead enrichment. Magnetic beads were pre-
cleared and incubated with Ssea-1 antibody at 4˚C for 30 minutes (1). Unbound antibody was removed (2) while 
the antibody bound beads were washed and then incubated with the single cell suspension at 4˚C for 20 minutes 
(3). Unbound cells were discarded (4) and Ssea-1 positive NSCs bound to the antibody-bead complex were 
washed and eluted in complete neural basal media containing 100 ng/ml Egf (5).  
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Figure 6: Embryonic forebrain-derived NSC in culture express Pax6. 
Microdissected E13.5 dorsal anterior forebrain cells were enriched for stem cell 
population using Ssea-1 antibody bound to magnetic beads (refer to Figure 5). 
NSC were expanded in culture to form neurospheres and were fixed for 
immunolabeling after one week. The NSC expressed the extracellular matrix 
protein, laminin (green) and the stem cell transcription factor, Pax6 (red). The 
overlay with DAPI-positive nuclei (blue) reveals the colocalization of the Pax6 in 
the nuclei of the cells with the scale bar indicated (50 µm).  
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Figure 7: Brain-derived vascular cells from mouse express cell-type 
appropriate markers. Brain microvascular endothelial cells (BMECs) and brain 
microvascular fibrobalsts (BMFbs) were grown as monocultures and fixed for 
immunolabeling. BMECs are able to bind the G. simplicifolia Lectin (green) and 
BMFbs express the smooth muscle version of the cytoskeletal protein, Smooth 
muscle actin (SMA; red). Nuclei are labeled with DAPI (blue). Scale bars are 50 
µm.   
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were able to grow under the influence of vascular signals from vascular cells at a 
distance (non-contact) or in contact to NSCs. BMFb and BMECs were plated on 
the bottom of the lower compartment in the non-contacting conditions and on the 
underside of the Transwell® membrane in the contacting condition while the 
NSCs were plated into the upper chamber and cultured for five days (Figure 8). 
Upon the fifth day, total RNA was extracted from the NSCs.  
 
Vascular cells influence gene expression changes in neural stem cells 
To determine differences in gene expression between NSCs grown with 
and without vasculature, NSC RNA was isolated and sent away for external 
quality control, library preparation, and RNA-sequencing at Novogene. Additional 
quality control procedures were followed that allowed us to look at dispersion of 
gene counts, sample variation, and clustering. The dispersion plots of the data 
can be seen in the Appendix (Figure 1). Variation in the sample expression 
values was visualized using a principal component analysis (PCA) (Figure 9) as 
well as a cluster analysis (Appendix, Figure 2). Although both analyses indicate 
that there are slight variations between the sample conditions, clustering can still 
be observed along one axis of the PCA scatterplot representing 47% of the 
variance in the system. 
Among the 10 samples sequenced, 6 contained minor genomic 
contamination that did not preclude sample sequencing. This genomic 
contamination is most likely a result of the use of gelatin, which perhaps limited 
the effectiveness of both the on-column and off-column DNase incubations  
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Figure 8: Neural-vascular heterotypic coculture system. To recapitulate the 
cellular microenvironment during brain development in vitro, NSCs are cultured in 
the upper compartments of the Transwell® inserts with and without the presence 
of vascular cells (BMFb and BMEC; red and green). In the Solo condition, NSCs 
are cultured alone (blue), similar to NSCs proliferating at the ventricular zone in 
vivo. NSCs are cultured in close proximity to vascular cells in the Non-Contact 
condition (CCN) and in direct contact in the Contact condition (CCC). The latter 
two conditions are designed to recapitulate the progression of developmental 
interactions between the NSCs and the vascular cells in vivo with regard to 
juxtacrine and paracrine signals in the cellular microenvironment as cortical 
development progresses. 
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Figure 9: Principal Component Analysis (PCA) of NSC RNA-Seq data. The 
RNA-Seq counts normalized per million reads were analyzed using PCA analysis 
via the DESeq2 package in R. The sample groups clustered along PC1 (47% 
variance) but displayed dispersion relative to PC2 (37% variance). The results for 
NSC grown in solo culture (Solo; blue, n=3), non-contacting coculture (CCN; 
green, n=3), and contacting coculture (CCC; red, n=4) with vascular cells are 
shown. 
 
 
 
 
	 45 
during RNA purification and re-precipitation. Gelatin is needed for the adherence 
of the vascular cells to the underside of the Transwell® membrane and is, 
therefore, necessary for culturing the three cell types together. To overcome this 
limitation, we modified our significance criteria to a false discovery rate (FDR) 
less than or equal to 0.05 and a base mean count greater than or equal to 100 
while using the DESeq2 package in R to identify differentially expressed genes 
(DEGs). We identified a total of 1073 DEGs from both non-contacting and 
contacting vascular coculture in comparison with NSCs grown in solo culture. A 
heatmap was generated to visualize the DEGs for NSCs in solo culture, in non-
contact (CCN) coculture, and contacting coculture (CCC) (Figure 10). Among 
these DEGs, 779 were found to be unique to non-contacting vascular coculture 
while 29 were unique to contacting vascular coculture. The top 10 DEGs from 
these comparisons are listed in Tables 1 and 2, respectively.  
There were 265 DEGs found in both vascular coculture conditions, 
independent of contact status. These 265 DEGs are of the most interest in the 
subsequent research due to the commonality of the presence of vascular cells. 
The top 10 DEGs up or down regulated in both vascular conditions are listed in 
Table 3 and include Stat3 and Gfap. The Jak/Stat pathway has been seen to be 
involved in gliogenesis and in the activation of Gfap for the formation of 
astrocytes [66].  
In order to validate the differential expression of Gfap in addition to other 
genes related to neural or glial cell fate quantitative real-time PCR (qPCR) was 
performed. Separate sources of RNA attained from independent experiments 
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Figure 10: NSCs in solo and vascular coculture express distinct 
transcriptomic profiles. A heatmap was generated by taking the log2 of the 
normalized counts for all differentially expressed genes (DEGs) for NSCs in solo 
culture, in non-contact (CCN) coculture, and contacting coculture (CCC). The 
blue and red colors represent z-scores for each gene, with red indicating higher 
than average expression and blue indicating lower than average expression of a 
particular gene. 
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Table 1: Top 10 differentially expressed genes (DEGs) in non-contacting 
vascular coculture (CCN). To determine differential gene expression in NSCs 
grown in the presence of non-contacting vascular cells, CCN conditions were 
compared to solo, which was designated as the baseline. DEGs were calculated 
using DESeq2 with a FDR ≤ 0.05 and Base Mean ≥ 100 to determine 
significance. 
 
 
 
 
 
 
 
 
 
 
CCN vs Solo 
Gene Log2 Fold Change FDR 
Stat3 1.057335743 1.69E-22 
Col18a1 1.314338805 1.69E-22 
Htr3a 1.740227416 1.46E-19 
Dio2 -1.329614519 2.52E-18 
Jak3 1.599106891 2.52E-18 
Cacng5 1.428117681 6.84E-18 
C4b 1.519069729 1.13E-16 
Arl4c 0.850639986 5.23E-16 
Sbno2 1.458696367 2.16E-15 
Gfap 1.415006246 2.67E-15 
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Table 2. Top 10 differentially expressed genes (DEGs) in contacting 
vascular coculture (CCC). To determine differential gene expression in NSCs 
grown in the presence of non-contacting vascular cells, CCC conditions were 
compared to solo, which was designated as the baseline. DEGs were calculated 
using DESeq2 with a FDR ≤ 0.05 and Base Mean ≥ 100 to determine 
significance. 
 
 
 
 
 
 
 
 
 
Table 3. Top 10 DEGs common to both vascular coculture conditions. To 
determine differential gene expression in NSCs grown in the presence of 
CCC vs Solo 
Gene Log2 Fold Change FDR 
Stat3 0.800603393 2.67E-13 
C4b 1.357914111 3.13E-13 
Col18a1 0.977352474 5.43E-13 
Jak3 1.303729142 4.48E-12 
Htr3a 1.278892306 3.99E-10 
Sbno2 1.090873918 3.23E-08 
Gfap 1.053364751 3.56E-08 
Dio2 -0.861401376 9.49E-08 
Cacng5 0.939041159 1.63E-07 
Thbs2 1.061570461 4.03E-07 
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vascular cells, coculture non-contact (CCN) and coculture contact (CCC) 
conditions were each compared to solo, which was designated as the baseline. 
The top 10 DEGs were found to be among the top 15 DEGs for each group 
individually. DEGs were calculated using DESeq2 with a FDR ≤ 0.05 and Base 
Mean ≥ 100 to determine significance.  
 
 
 
 
 
 
 
 
 
 
using different litters of mice were used to generate cDNA for analysis. The 
reference genes 18S, Gapdh, and Hprt were used to assess sample to sample 
variation as well as variation between treatment conditions (Figure 11). Although 
 CCN vs Solo CCC vs Solo 
Gene Log2 Fold Change FDR Log2 Fold Change FDR 
Stat3 1.057335743 1.69E-22 0.800603393 2.67E-13 
Col18a1 1.314338805 1.69E-22 0.977352474 5.43E-13 
Htr3a 1.740227416 1.46E-19 1.278892306 3.99E-10 
Jak3 1.599106891 2.52E-18 1.303729142 4.48E-12 
Dio2 -1.329614519 2.52E-18 -0.861401376 9.49E-08 
C4b 1.519069729 1.13E-16 1.357914111 3.13E-13 
Cacng5 1.428117681 6.84E-18 0.939041159 1.63E-07 
Sbno2 1.458696367 2.16E-15 1.090873918 3.23E-08 
Gfap 1.415006246 2.67E-15 1.053364751 3.56E-08 
Thbs 1.415006246 2.67E-15 1.061570461 4.03E-07 
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there is some variation within the treatment conditions, there is no significant 
difference between conditions. 
Cell type-specific genes were used to investigate whether or not the 
presence of non-contacting or contacting vasculature influenced NSC fate choice 
(Figure 12). The gene Pax6 was used to identify neural epithelial cells and the 
gene Tbr2 was used for intermediate progenitor cells. To investigate 
differentiating NSC populations, the neuronal gene Calbindin 1, and glial gene 
Gfap were used.  
There were no significant differences in the expression of Pax6 (Kruskal-
Wallis, p=0.400) and Tbr2 (Kruskal-Wallis, p=0.0520); however, both Calbindin 1 
(one way ANOVA, p=0.0162) and Gfap (Kruskal-Wallis, p=0.0016) were found to 
be significantly different in vascular coculture conditions (Figure 12). Multiple 
comparisons identified that Calbindin 1 transcript expression was significantly 
different between Solo and CCC (Tukey’s post hoc, p=0.0121) and Gfap 
transcript expression was significantly different between Solo and CCN (Dunn’s 
post hoc, p=0.0011).  
To determine if these differences in neuronal and glial transcript 
expression were also observed at the protein level in the NSC culture conditions, 
western blot analysis was used. Primary antibodies were chosen to detect 
proteins expressed RGCs, intermediate progenitors, and in neural or glial cell 
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Figure 11: Reference gene expression is not significantly different in 
coculture NSCs. Ssea-1 enriched NSCs were cultured alone (Solo) and in the 
presence of non-contacting (CCN) and contacting (CCC) vascular cells in the 
Transwell® coculture system. Total RNA was collected on day 5 and was reverse 
transcribed into cDNA. Reference genes 18S, Gapdh, and Hprt were used to 
assess experimental and biological variation. A total of 2-3 experiments were 
used for the Kruskal-Wallis analysis (red, green, and blue) with n=9 for Solo, 
n=12 for CCN and n=11 for CCC; whiskers extend from minimum to maximum. 
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Figure 12: Coculture NSCs maintain stem cell populations but also exhibit 
differences in neuronal and glial markers. Ssea-1 enriched NSCs were 
cultured alone (Solo) and in the presence of non-contacting (CCN) and 
contacting (CCC) vascular cells in the Transwell® coculture system. Total RNA 
was collected on day 5 and was reverse transcribed into cDNA. A total of 2-3 
experiments were used for the Kruskal-Wallis and one-way ANOVA analysis 
(red, green, and blue) with n=9 for Solo, n=12 for CCN and n=11 for CCC. 
Whiskers extend from minimum to maximum and error bars indicate standard 
deviation. “*” denotes significance (“*” p=0.01-0.05, “**” p=0.001-0.01). 
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lineages. The protein Blbp is expressed in RGCs and the protein Tbr2 is 
expressed in intermediate progenitor cells. The protein Id4 is expressed in neural 
precursors and the protein Gfap is expressed in glial cells.  
Although not significant, the expression of radial glia protein Blbp (Kruskal-
Wallis, p=0.1389), intermediate progenitor protein Tbr2 (Kruskal-Wallis, 
p=0.8847), and neural protein Id4 (Kruskal-Wallis, p=0.3946) showed decreasing 
trends (Figure 13). Gfap protein expression increased significantly under 
coculture conditions (Kruskal-Wallis, p=0.0407). Multiple comparisons identified 
that this increase in Gfap protein expression in CCC was significantly different 
than Solo (Dunn’s post hoc, p=0.0441). These results, in addition to the transcript 
expression indicate that the presence of the vasculature shifts expression of glial 
and neuronal genes. The data also illustrates that the population of NSCs is 
heterogeneous reflecting the cellular dynamics of the developing cortex. 
To visualize NSC Gfap expression while in coculture, NSCs were labeled on the 
Transwells® using immunohistochemistry (IHC) (Figure 14). Gfap expression can 
be seen to a small extent in the Solo condition, but much greater in CCC. This 
reflects the amount of expression seen in the western blot analysis. In addition, 
the NSCs in CCC exhibit a drastic change in morphology compared to Solo and 
CCN, and appear to follow the path of the vascular cells (not shown) below.  
 
Pathway analysis identifies enriched signaling mechanisms 
To better understand how NSC gene expression shifts in the context of 
the cellular microenvironment, the lists of DEGs from the non-contacting 
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Figure 13: Western blot analysis of neural stem cells grown in coculture.  
Ssea-1 enriched NSCs were cultured in the Transwell® coculture system alone 
(Solo) and in the presence of non-contacting (CCN) and contacting (CCC) 
vascular cells. Total protein was extracted form the NSCs and concentrations 
determined. A 30 µg protein was loaded on a SDS-PAGE gel and blotted with 
antibodies against Glial fibrillary acidic protein (Gfap), T-Box Brain2 
(Tbr2/Eomes), Inhibitor of DNA binding 4 (Id4), Brain lipid-binding protein 
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(Blbp/Fabp7). Data was analyzed using a Kruskal-Wallis test with a Dunn’s post 
hoc test to indicate significant differences between coculture conditions; whiskers 
extend from minimum to maximum, “*” denotes significance (“*” p=0.01-0.05), n= 
8 (Gfap, Tbr2, Id4), n=6 (Blbp). 
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Figure 14: NSCs in coculture express Gfap. Microdissected E13.5 dorsal 
anterior forebrain cells were enriched for stem cell population using Ssea-1 
antibody bound to magnetic beads (refer to Figure 5). NSC were cultured in 
vascular coculture conditions for 5 days (refer to Figure 8). The NSC expressed 
the intermediate filament, Gfap (red) with DAPI labeled nuclei (blue). Note the 
distinct shape change associated with direct contacting vascular coculture. Scale 
bars are 50 µm.  
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coculture (CCN) versus solo and the contacting coculture (CCC) versus solo 
were uploaded into Ingenuity Pathway Analysis (IPA®, Qiagen, Gaithersburg, 
MD), a bioinformatics tool that can be used to identify selectively enriched 
biological pathways in large datasets, including RNA-Seq results. Each list was 
analyzed using the Core Analysis tool with a FDR of 0.05. The top canonical 
pathways and biological functions (diseases and disorders, molecular and 
cellular functions, and physiological system development) identified as 
differentially enriched in CCN and CCC are listed in Table 4 and 5, respectively.  
Interestingly, among the top altered canonical pathways in CCN and CCC 
was ”interleukin-6 (IL-6) cytokine signaling”. Leukemia inhibitory factor, Lif, which 
is a member of the IL-6 family, has been found to play a role in the activation and 
development of astrocytes [18, 19] and reviewed in [58]. Major components of 
this pathway that were differentially expressed in the RNA-Seq analysis included 
janus kinase (JAK) and signal transducer and activator of transcription (Stat). As 
mentioned earlier, Stat3 is able to enter the nucleus and bind to the Gfap 
promoter to activate Gfap expression and thus induce gliogenesis [65, 66].  
Since Gfap was one of our top 10 DEGs in both vascular conditions, we 
wanted to see if Lif was expressed at the right time and place to be involved in 
the cell fate decisions seen in the coculture NSCs. Although we did not detect Lif 
expression in the NSCs from our transcriptome study, we have observed Lif 
expression in the BMFb a preliminary RNA-Seq analysis of vascular coculture 
(data not shown). We detected the most notable increase in Gfap expression in 
the NSC coculture conditions; so, we quantified Lif expression via ELISA on the 
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media conditioned from solo and vascular coculture NSCs (Figure 15). A 
Kruskal-Wallis test confirmed that there was a significant difference in the 
amount of Lif present between the culture groups (p=0.0240). Specifically there 
was a significant increase in Lif in CCN compared to solo (Dunn’s post hoc, 
p=0.0440). This increase in Lif in the conditioned medium parallels the increase 
in Gfap expression seen in vascular coculture.  
The IPA ® analysis also indicated that cell movement may be affected in 
NCS cultured in both CCN and CCC conditions. To investigate this, we ran 
additional qPCR with genes involved in NSC migration: Chemokine receptors 4 
(Cxcr4) and 7 (Cxcr7), and Chemokine ligand 12 (Cxcl12). The CXCL12-R4-R7 
signaling axis has been shown to be critical for normal cortex based on gene 
recombination studies with mice in which cerebellar and hippocampal migration 
was abnormal [116, 117]. In our coculture system, there was a significant 
difference in the expression of Cxcr7 (Kruskal-Wallis, p=0.0026), but not in the 
expression of Cxcr4 (Kruskal-Wallis, p=0.0674) (Figure 16). Transcript levels for 
Cxcl12 were undetectable (data not shown). A multiple comparison test found 
that Cxcr7 transcript expression significantly increased in CCC compared to solo 
(Dunn’s post hoc, p=0.0019) indicating that NSC express the receptors 
appropriate to respond to Cxcl12 in the microenvironment. 
 
Histone modification in NSC in response to vascular cells 
As a first exploratory measure, we performed a global histone modification 
assay (EpiGentek). This assay was able to quantify levels of 21 different histone 
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Table 4: Top canonical pathways and biological functions altered in Non-
Contacting Coculture as presented by Ingenuity Pathway Analysis (IPA®). 
The list of DEGs (FDR ≤ 0.05 and Base Mean ≥ 100) were uploaded into IPA® 
and analyzed using the Core Analysis. The p-values reflect the amount of DEGs 
uploaded that correspond to the total number of genes associated with a 
particular pathway or functional group within the IPA® software and were 
calculated using the Fisher Exact Test. 
Canonical Pathways p-value Genes 
Calcium Signaling  1.27E-10 33/203 
Hepatic Fibrosis / Hepatic Stellate Cell Activation 7.07E-08 27/186 
Role of NFAT in Cardiac Hypertrophy  2.91E-07 29/224 
IL-6 Signaling  
 
5.45E-07 21/134 
Diseases and Disorders p-value range # Molecules 
Cancer  1.51E-06 - 1.33E-38 924 
Organismal Injury and Abnormalities  1.54E-06 - 1.33E-38 936 
Gastrointestinal Disease  1.02E-06 - 2.12E-34 876 
Reproductive System Disease  4.93E-07 - 8.53E-25 637 
Neurological Disease  
 
1.54E-06 - 7.01E-23 432 
Molecular and Cellular Functions   
Cellular Movement  1.13E-06 - 2.16E-27 292 
Cell Death and Survival  1.54E-06 - 2.62E-20 368 
Cell Morphology  1.81E-06 - 2.24E-18 232 
Cellular Assembly and Organization  1.31E-06 - 7.95E-15 226 
Cellular Function and Maintenance  
 
1.75E-06 - 7.95E-15 335 
Physiological system development and function  
Nervous System Development and Function  1.64E-06 - 1.59E-27 301 
Organismal Survival  1.24E-08 - 5.32E-23 308 
Cardiovascular System Development and Function  1.20E-06 - 1.75E-22 219 
Organismal Development  1.71E-06 - 1.02E-21 421 
Behavior  1.24E-07 - 5.37E-21 160 
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Table 5: Top canonical pathways and biological functions altered in 
Contacting Coculture as presented by Ingenuity Pathway Analysis (IPA®). 
The list of DEGs (FDR ≤ 0.05 and Base Mean ≥ 100) were uploaded into IPA® 
and analyzed using the Core Analysis. The p-values reflect the amount of DEGs 
uploaded that correspond to the total number of genes associated with a 
particular pathway or functional group within the IPA® software and were 
calculated using the Fisher Exact Test. 
Canonical Pathways p-value Genes 
Hepatic Fibrosis / Hepatic Stellate Cell Activation 1.18E-07 14/186 
IL-6 Signaling  1.16E-06  11/134 
Acute Phase Response Signaling  2.70E-06 12/176 
IL-10 Signaling 
 
2.69E-05 7/69 
Diseases and Disorders p-value range # Molecules 
Cancer  8.89E-05 - 6.10E-24 270 
Organismal Injury and Abnormalities  9.16E-05 - 6.10E-24 271 
Gastrointestinal Disease  3.95E-05 - 1.68E-18 263 
Reproductive System Disease  8.80E-05 - 3.51E-16 637 
Hepatic System Disease 
 
3.95E-05 - 3.78E-13 432 
Molecular and Cellular Functions   
Cellular Movement  7.93E-05 - 7.00E-17 105 
Cellular Development 8.64E-05 - 9.74E-11 121 
Cell Morphology  7.11E-05 - 1.08E-10 78 
Cell Death and Survival 1.00E-04 - 7.44E-10 118 
Cellular Growth and Proliferation 
 
8.64E-05 - 1.69E-08 112 
Physiological system development and function  
Nervous System Development and Function  8.25E-05 - 2.42E-16 105 
Connective Tissue Development and Function 7.52E-05 - 2.99E-12 79 
Skeletal and Muscular System Development and 
Function 
7.52E-05 - 2.99E-12 52 
Tissue Development 8.64E-05 - 2.99E-12 130 
Cardiovascular System Development and Function 7.68E-05 - 1.12E-11 65 
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Figure 15: Leukemia inhibitory factor (Lif) expression increases in non-
contacting vascular coculture. Cell culture medium was collected after 5 days 
and centrifuged to remove cell debris. The level of mouse Lif was quantified 
using a sandwich ELISA and compared to a standard curve with a minimum 
sensitivity of 3-5 pg/ml for purified Lif. Diluent alone and complete Neurobasal 
medium were both used as negative controls and had undetectable levels of Lif. 
Values from a total of 2 experiments with n=7 were used for the Kruskal-Wallis 
and Dunn’s post hoc analysis. Whiskers extend from minimum to maximum 
points; “*” indicates significance (“*” p=0.01-0.05). 
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Figure 16: Chemokine receptors Cxcr7 and Cxcr4 are expressed in NSC in 
solo and vascular coculture. Ssea-1 enriched NSCs were cultured alone (Solo) 
and in the presence of non-contacting (CCN) and contacting (CCC) vascular 
cells in the Transwell® coculture system. Total RNA was collected on day 5 and 
was reverse transcribed into cDNA. A total of 2-3 experiments were used for the 
Kruskal-Wallis analysis (red, green, and blue) with n=9 for Solo, n=12 for CCN 
and n=11 for CCC. Whiskers extend from minimum to maximum; “*” denotes 
significance (“**” p=0.001-0.01). 
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modifications in our NSC coculture samples (Appendix Figure 3). The H3K27 
methylation states were among the most notable histone modifications detected 
and 2-way ANOVA analysis for culture condition and methylation state indicated 
that methylation status (me1, me2, me3) accounted for a significant amount of 
the total variance among the samples (37.69%, p=0.0041; F= 7.21; DFn=2; 
DFd=21). However, no individual pairwise comparisons were significantly 
different among our coculture conditions (Figure 17).  
The methylation of these histones is related to the functioning of the 
Polycomb repressive complex 2 (PRC2). PRC2 is a member of the Polycomb-
group protein family; the Ezh1/2 component is responsible for the histone 
methyltransferase function of this complex and has the ability to mono-, di-, and 
tri- methylate lysine 27 on histone H3 (H3K27me1, H3K27me2, and H3K27me3) 
[25, 108]. Previous research has identified PRC2 to be a major contributor to 
NSC fate choice decisions [27, 118] and when Ezh2 is blocked during 
neurogenesis, there is a decrease in H3K27me3 in neural progenitor cells 
Pereira, 2010 #92}. This information guided our research in setting up a cell 
culture paradigm to inhibit Ezh2 to investigate the role of PRC2 in cell fate 
determination. 
 
Effect of Ezh2 inhibition and vascular cell-induced signaling on NSC 
fate choice 
To determine the role of Ezh2, and thus PRC2, in the changes in NSC fate 
we observed in the coculture system, we utilized the Ezh2 inhibitor, EI1. The use 
of an inhibitor is not feasible in the direct coculture system due to the multiple cell 
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Figure 17: Vascular cells influence the H3K27 methylation states in NSCs. 
Ssea-1 enriched NSCs were cultured alone (Solo) and in the presence of non-
contacting (CCN) and contacting (CCC) vascular cells in the Transwell® coculture 
system. Histone protein was extracted and 50 ng was used in a histone H3 
modification assay (EpiGentek). Error bars indicate standard deviation and n=3-4 
for each condition.  
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types present and potentially affected. Therefore, a modified culture model had to 
be established that allowed NSCs to be exposed to vascular signals, just as with 
the coculture system. To achieve this, vascular cell conditioned media (CM) was 
generated by plating BMECs and BMFbs 1:1 on a petri dish in the basic assay 
medium for coculture, complete NB medium with 20 ng/ml Egf for 5 days (Figure 
17). Upon the 5th day, the CM was collected, centrifuged, and filtered to remove 
cell debris. To replenish any nutrients that may have been depleted by the 
vascular cells, complete NB medium (20 ng/ml Egf) was added to the CM (1:1) 
prior to use.  
This CM can be utilized in combination with the Ezh2 inhibitor in a two-by-
two factorial design to test the effects of vascular cell-derived signals and Ezh2 
on NSC fate choice. Thus, the culture conditions are complete NB medium (20 
ng/ml Egf), complete NB medium with CM (20 ng/ml Egf), complete NB medium 
with Ezh2 inhibitor (20 ng/ml Egf, 10 µM EI1) and complete NB with CM and 
Ezh2 inhibitor (20 ng/ml Egf, 10 µM EI1) (Figure 18). NSCs were cultured on 
plastic in these culture conditions for five days and generated neurospheres akin 
to those in the Transwell cultures. Both E11.5 and E13.5 NSC time points were 
used to determine the effect of isolation time point on NSC plasticity due to the 
fact that E11.5 NSCs have had less exposure to vascular signals in vivo than 
E13.5.  
To determine if the CM altered cell fate in NSC in the presence or 
absence of Ezh2 Inhibitor, we quantified gene expression for key target genes as 
previously described. As with the coculture samples, the reference genes 18S 
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Figure 18: Modeling vascular signals in the presence of Ezh2 inhibitor. To 
isolate soluble signaling factors produced by the vascular cells in the coculture 
experiment, endothelial cells and fibroblasts were plated 1:1 on a plastic dish and 
are cultured in Complete Neural basal medium (NB; 20 ng/ml EGF) for five days. 
Upon the fifth day, the media was collected, centrifuged to remove large debris 
and then filtered. Neurospheres were disrupted through incubation with 
StemPro® Accutase® (Gibco®) at 37˚C for 10 min, re-suspended in NB and plated 
as a single cell suspension in 0.5 ml on day 0. On day 1, the cells begin their 
treatment period and are cultured in four conditions: NB (20 ng/ml Egf), NB with 
EI1 (20 ng/ml Egf, 10 µM EI1), CM (20 ng/ml Egf), CM with EI1 (20 ng/ml Egf, 10 
µM EI1).  
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and Gapdh were used to assess sample-to-sample variation in addition to 
variation between treatment conditions. A two-way ANOVA found no significant 
interactions of main effects in either media type or inhibitor on 18S and Gapdh 
expression at E11.5 in addition to the 18S expression at E13.5. There was an 
effect for media type on Gapdh expression at E13.5 (Table 6) in which there was 
a significant increase in Gapdh transcript expression in CM compared to NB 
(Tukey’s post hoc, p=0.0134) and NB with Ezh2 inhibitor (Tukey’s post hoc, 
p=0.0370) as well as a significant increase in CM with Ezh2 inhibitor compared to 
NB (Tukey’s post hoc, p=0.0017) and NB with Ezh2 inhibitor (Tukey’s post hoc, 
p=0.0053; Figure 19). This indicates that CM may alter glucose metabolism 
E13.5 time point.  
Cell type-specific genes were used to investigate whether or not the 
presence of conditioned medium or Ezh2 inhibitor influenced NSC fate choice 
from NSC derived from E11.5 forebrain (Figure 20). The gene Pax6 was used to 
identify neural epithelial cells, Tbr2 was used for intermediate progenitor cells 
and to investigate differentiating NSC populations, the neuronal gene Calbindin 
1, and the glial gene Gfap were used. A two-way ANOVA found no significant 
interactions due to either media type or inhibitor on the expression of Pax6 or 
Tbr2 in E11.5 NSC. There was an effect for the presence of the inhibitor on 
Calbindin 1 in which levels of NSC expression of Calbindin 1 in NB was 
significantly lower than in NB with Ezh2 inhibitor (Tukey’s Post hoc, p=0.0064) 
and NB with Ezh2 inhibitor was significantly higher than CM (Tukey’s Post hoc, 
p=0.0136). There were significant main effects for both the media type and the 
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Figure 19: Expression of Gapdh is altered in NSCs isolated at E13.5. Ssea-1 
enriched E11.5 and E13.5 NSCs were cultured in NB or Conditioned medium 
(CM) and with and without an Ezh2 inhibitor. Total RNA was collected on day 5 
and was reverse transcribed into cDNA. Reference genes 18S and Gapdh were 
used to assess experimental and biological variation. The data was analyzed 
using a two-way ANOVA with a Tukey’s post hoc. The E11.5 time point 
contained one experiment (n=5-6) and the E13.5 time point contained two 
experiments (n=9). Error bars indicate standard deviation and “*” denotes 
significance (“*” p=0.01-0.05, “**” p=0.001-0.01).
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Table 6: ANOVA table for Reference Genes. A two-way ANOVA was run on the reference genes 18S and Gapdh 
for E11.5 and E13.5 NSCs cultured with and without Conditioned medium and with and without Ezh2 inhibitor. The 
E11.5 time point contained one experiment (n=5-6) and the E13.5 time point contained two experiments (n=9). 
Refer to Figure 19 for graphical representation of qPCR data.  
 
Time point Gene ANOVA table DF F (DFn, DFd) P value 
E11.5 18S Interaction 1 F (1, 19) = 1.592 P=0.2223 
  Media 1 F (1, 19) = 0.03416 P=0.8553 
  Inhibitor 1 F (1, 19) = 1.406 P=0.2504 
  Residual 19   
E11.5 Gapdh Interaction 1 F (1, 18) = 1.748 P=0.2027 
  Media 1 F (1, 18) = 0.04415 P=0.8359 
  Inhibitor 1 F (1, 18) = 0.001926 P=0.9655 
  Residual 18   
E13.5 18S Interaction 1 F (1, 32) = 0.1012 P=0.7525 
  Media 1 F (1, 32) = 0.4617 P=0.5017 
  Inhibitor 1 F (1, 32) = 0.07785 P=0.7820 
  Residual 32   
E13.5 Gapdh Interaction 1 F (1, 32) = 0.06377 P=0.8023 
  Media 1 F (1, 32) = 23.64 P<0.0001 
  Inhibitor 1 F (1, 32) = 0.7126 P=0.4049 
  Residual 32   
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presence of inhibitor for Gfap transcript expression (Table 7) where NB is 
significantly lower than NB with Ezh2 inhibitor (Tukey’s Post hoc, p=0.0097), NB 
is significantly lower than CM (Tukey’s Post hoc, p=0.0002), NB is significantly 
lower than CM with Ezh2 inhibitor (Tukey’s Post hoc, p<0.0001), and NB with 
Ezh2 inhibitor is significantly lower than CM with Ezh2 inhibitor (Tukey’s Post 
hoc, p=0.0290; Figure 20).  
For the E13.5 NSCs that have already been exposed to both contacting 
and non-contacting vasculature prior to primary isolation, we conducted the same 
analysis for cell-type specific genes (Figure 21). The gene Pax6 was used to 
identify neural epithelial cells. Vimentin was used to identify RCGs, Tbr2 was 
used for intermediate progenitor cells and Gfap was used to identify glia. A two-
way ANOVA found no significant interactions or main effects for Vimentin, 
however there was a significant main effect for both Pax6 and Tbr2, but no 
significant differences were found between treatment conditions (Table 8). There 
were significant main effects for both the media type and the presence of Ezh2 
inhibitor on Gfap expression where CM significantly decreased compared to NB 
(Tukey’s Post hoc, p=0.0306) and NB with Ezh2 inhibitor (Tukey’s Post hoc, 
p<0.0001). CM with Ezh2 inhibitor also significantly decreased compared to NB 
with Ezh2 inhibitor (Tukey’s Post hoc, p=0.0001) (Figure 21). 
The results of the two embryonic time points indicate that neural epithelial 
and RGC gene transcripts are still being expressed. In addition, the neural and 
glial lineage gene transcript expression indicates that the culture conditions are 
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Figure 20: Neural and glial genes are altered in E11.5 NSCs cultured in 
conditioned medium and in the presence of Ezh2 inhibitor. Ssea-1 enriched 
E11.5 NSCs were cultured in NB or Conditioned medium (CM) and with and 
without an Ezh2 inhibitor. Total RNA was collected on day 5 and was reverse 
transcribed into cDNA. The gene Pax6 was used to identify neural epithelial cells, 
Tbr2 was used for intermediate progenitor cells, the neuronal gene Calbindin 1, 
and glial gene Gfap were used to investigate differentiating NSC populations. 
The data contained one experiment (n=5-6) and was analyzed using a two-way 
ANOVA with a Tukey’s post hoc. Error bars indicate standard deviation and “*” 
denotes significance (“*” p=0.01-0.05, “**” p=0.001-0.01, “***” p=0.0001-0.001, 
“****” p<0.0001).
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Table 7: ANOVA table for cell fate genes expressed in E11.5 NSCs. A two-way ANOVA was run on the genes 
Pax6, Tbr2, Calbindin 1, and Gfap for E11.5 NSCs cultured with and without Conditioned medium and with and 
without Ezh2 inhibitor. The data represent one experiment (n=5-6). Refer to Figure 20 for graphical representation 
of qPCR data.
Gene ANOVA table DF F (DFn, DFd) P value 
Pax6 Interaction 1 F (1, 18) = 1.896 P=0.1854 
 Media 1 F (1, 18) = 1.886 P=0.1866 
 Inhibitor 1 F (1, 18) = 1.633 P=0.2175 
 Residual 18   
Tbr2 Interaction 1 F (1, 19) = 2.543 P=0.1273 
 Media 1 F (1, 19) = 0.6859 P=0.4178 
 Inhibitor 1 F (1, 19) = 3.923 P=0.0623 
 Residual 19   
Calbindin 1 Interaction 1 F (1, 18) = 2.128 P=0.1619 
 Media 1 F (1, 18) = 1.458 P=0.2428 
 Inhibitor 1 F (1, 18) = 13.55 P=0.0017 
 Residual 18   
Gfap Interaction 1 F (1, 19) = 1.984 P=0.1751 
 Media 1 F (1, 19) = 34.38 P<0.0001 
 Inhibitor 1 F (1, 19) = 12.56 P=0.0022 
 Residual 19   
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Figure 21: Conditioned medium decreases Gfap expression in E13.5 NSC. 
Ssea-1 enriched E13.5 NSCs were cultured in NB or Conditioned medium (CM) 
and with and without an Ezh2 inhibitor. Total RNA was collected on day 5 and 
was reverse transcribed into cDNA. The gene Pax6 was used to identify neural 
epithelial cells, Vimentin was used to identify RCGs, Tbr2 was used to identify 
intermediate progenitor cells and Gfap was used to investigate glial populations. 
The data contained two experiments (n=9) and was analyzed using a two-way 
ANOVA with a Tukey’s post hoc. Error bars indicate standard deviation and “*” 
denotes significance (“*” p=0.01-0.05, “***” p=0.0001-0.001, “****” p<0.0001). 
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Table 8: ANOVA table for cell fate genes expressed in E13.5 NSCs. A two-way ANOVA was run on the genes 
Pax6, Vimentin, Tbr2, and Gfap for E13.5 NSCs cultured with and without Conditioned medium and with and 
without Ezh2 inhibitor. The data contained two experiments (n=9). Refer to Figure 21 for graphical representation 
of qPCR data.
Gene ANOVA table DF F (DFn, DFd) P value 
Pax6 Interaction 1 F (1, 32) = 0.1806 P=0.6737 
 Media 1 F (1, 32) = 0.1396 P=0.7112 
 Inhibitor 1 F (1, 32) = 6.252 P=0.0177 
 Residual 32   
Vimentin Interaction 1 F (1, 32) = 0.05141 P=0.8221 
 Media 1 F (1, 32) = 2.391 P=0.1319 
 Inhibitor 1 F (1, 32) = 0.2275 P=0.6367 
 Residual 32   
Tbr2 Interaction 1 F (1, 32) = 0.6478 P=0.4268 
 Media 1 F (1, 32) = 4.503 P=0.0417 
 Inhibitor 1 F (1, 32) = 1.465 P=0.2351 
 Residual 32   
Gfap Interaction 1 F (1, 32) = 2.086 P=0.1584 
 Media 1 F (1, 32) = 31.11 P<0.0001 
 Inhibitor 1 F (1, 32) = 5.224 P=0.0290 
 Residual 32   
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influencing NSC fate decisions. It seems that at E11.5, the vascular CM induces 
NSC differentiation down the glial pathway and, as expected, also in the 
presence of Ezh2 inhibitor. Although Gfap transcript expression in NB increased 
with the addition of Ezh2 inhibitor at E13.5, different results were seen when 
analyzing the effect of the CM, where Gfap expression decreased. 
To determine if these differences in neuronal and glial transcript 
expression were also observed at the protein levels in the conditioned media and 
Ezh2 inhibitor culture conditions western blot analysis was performed. As with 
the coculture western blot, primary antibodies were chosen to detect proteins 
expressed RGCs (Blbp) and glial cell (Gfap) lineages. Although no significant 
main effects were determined from a two-way ANOVA, the expression of Blbp 
decreased in CM compared to NB and also decreased in the presence of Ezh2 
inhibitor whereas Gfap expression in NB increased with the presence of the 
inhibitor (Figure 22, Table 9). In addition, these Gfap protein expression results 
also reflect the same trend as seen with the E13.5 qPCR data. 
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Figure 22: Inhibition of Ezh2 impacts Gfap expression in E13.5 NSC. Ssea-1 
enriched E13.5 NSCs were cultured in NB or Conditioned medium (CM) with and 
without an Ezh2 inhibitor. Total protein was extracted from the NSCs and 
concentrations determined. A total of 10µg protein was loaded on a SDS-PAGE 
gel and blotted with antibodies against Glial fibrillary acidic protein (Gfap) and 
Brain lipid-binding protein (Blbp/Fabp7). Data was analyzed using a two-way 
ANOVA with a Tukey’s post hoc test to indicate significant differences between 
culture conditions; error bars indicate standard deviation, n= 3. 
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Table 9: ANOVA table for cell fate genes expressed in western blot. A two-way ANOVA was run on the 
expression of Gfap and Blbp protein for E13.5 NSCs cultured with/without Conditioned medium and with/without 
Ezh2 inhibitor (n=3). Refer to Figure 22 for graphical representation of western blot data.
Gene ANOVA table DF F (DFn, DFd) P value 
Gfap Interaction 1 F (1, 32) = 0.1806 P=0.6737 
 Media 1 F (1, 32) = 0.1396 P=0.7112 
 Inhibitor 1 F (1, 32) = 6.252 P=0.0177 
 Residual 8   
Blbp Interaction 1 F (1, 8) = 0.02863 P=0.8698 
 Media 1 F (1, 8) = 2.749 P=0.1359 
 Inhibitor 1 F (1, 8) = 0.2374 P=0.6392 
 Residual 8   
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CHAPTER IV 
DISCUSSION 
Cortical development is a complex process that requires the coordinated 
interaction of different cell types in the same microenvironment to generate a 
functional tissue. Through cell-cell communication and signal transduction, the 
different cell types are able to interact effectively with each other during 
developmental progression. The primary goal of this thesis research was to 
investigate how NSCs respond to a vascular microenvironment. A secondary 
goal was to determine if NSC fate choice is intrinsic or if the vasculature provides 
extrinsic cues that alter gene expression and, if so, by what mechanism. 
Previous studies from others have tried to model the same interactions between 
the NSCs and vasculature, but have predominantly used ECs [60, 119, 120]. The 
current study used both ECs and perivascular cells due to the fact that both cell 
types are required in normal blood vessel formation (angiogenesis) and function. 
By using these two cell types, derived from brain vasculature, in our novel 
heterotypic coculture system, the interactions between the developing cortical 
vasculature and the NSCs can be better recapitulated and modeled in vitro.  
Classically, neurogenesis and gliogenesis were considered two distinct 
processes, with neural progenitors producing neurons and RGCs, which express 
glial marker, Gfap, producing glia. However, studies in the early 2000’s led to the 
discovery that RGCs are proliferative, can express Gfap, and are able to give rise 
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to both neurons and glia in the central nervous system, both during development 
and in the adult (Reviewed in [121]. Even though there is an overlap in Gfap 
expression between RGCs and their differentiated progeny, Gfap is still used as 
an assessment of gliogenesis. For the present study, we wanted to use 
additional markers to elucidate differential expression of Gfap; therefore, we used 
the neural epithelial marker, Pax6 [30] and RGC markers Blbp [29] and Vimentin 
[122]. Others have shown co-labeling of RGC markers with Pax6 [123]; however, 
this coexpression has only been observed at later time points (E14.5-E16.5). The 
current study focused on earlier time points (E11.5 and E13.5) to take advantage 
of the critical vascular investment phase of the developing cortex. Our hypothesis 
is that the vascular cells direct NSC fate during cortical angiogenesis through 
factors released by the vasculature that modify the epigenetic landscape in the 
NSC. 
 As an initial step to address this hypothesis, we took an unbiased 
approach to determine how vascular cells affected NSC differentiation. We were 
able to identify a total of 1084 DEGs in NSCs cultured with vascular cells in our 
coculture system versus NSCs grown solo. Furthermore, we observed that these 
NSCs in vascular coculture differentiate and become positive for the glial marker 
Gfap and the neural marker Calbindin 1 as shown in both the qPCR and western 
blot analysis. This indicates that the vasculature does provide extrinsic cues, 
most likely through the release of soluble factors, which act to alter NSC gene 
expression.  
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To better understand these soluble factors and their involvement in NSC 
fate decisions, we assessed our transcriptome data for cohorts of genes, linked 
by their involvement in common signaling pathways, using IPA® Core analysis. 
Many of the DEGs were found to be included in pathways and groups that 
involved the general development or disease states of the central nervous 
system. One pathway of particular interest was “IL-6 signaling”. This pathway is 
important for mediating a variety of cell responses, particularly in the immune 
system (Reviewed in [124]). However, it has also been shown to be involved in 
the activation and development of astrocytes [66]. Based on this latter 
association, we investigated the IL-6 family member, Lif, which has been shown 
previously to promote downstream expression of Gfap in E14.5 NSCs [125]. 
Using a Lif ELISA, we found that there were increases in the concentration of Lif 
protein in the culture media generated by the combination of NSCs and vascular 
cells in Transwell® coculture compared to NSCs in Solo. This increase in Lif in 
the presence of vascular cells provides a possible mechanism as to how the 
change in NSC fate is being directed. 
One important consideration regarding how microenvironmental signals 
are translated within a cell concerns epigenetic regulation of gene transcription to 
regulate changes in the transcriptome. To understand how the NSCs are 
responding to microenvironmental cues such as IL-6/Lif signaling, we first looked 
at histone modifications. Our lab has previously shown that shifts in Vegf isoform 
expression in early cortical development resulted in altered expression of PRC2 
components, Suz12 and Ezh2 based on microarray comparisons of wild-type 
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mice with those expressing only single or combinations of Vegf isoforms [89, 90]. 
Therefore, we wanted to explore the possibility that H3K27me3, a major 
repressive mark generated by PRC2 [126] might be critical for mediating the 
NSC response to vascular cell investment. Recent reviews have highlighted the 
wave of investigations regarding epigenetic mechanisms that mediate many key 
transitional changes in development and disease in the nervous system [127-
129]. In our heterotypic culture system, we also observed differences in 
methylation of H3K27 in NSC linked to vascular cell influence. We investigated a 
potential role for PRC2 in mediating cell fate changes. The Ezh2 component of 
PRC2 is responsible for the methylation of H3K27 [126]; therefore, we used a 
commercially available Ezh2 inhibitor [113] to see how PRC2 affects NSC gene 
expression. Interestingly, we found that the embryonic time point from which the 
NSCs were isolated made a difference in how the cells respond to both the 
vascular CM as well as the Ezh2 inhibitor with the E11.5 NSC being sensitive to 
the inhibitor and CM. We observed differential Gapdh expression in E13.5 NSCs 
(not in E11.5 NSCs) treated with CM and/or Ezh2 inhibitor. This latter result 
suggests the intriguing possibility that the CM is causing a change in glucose 
metabolism at E13.5 but not E11.5 or that there is a differential vulnerability in 
terms of glucose use and media depletion at these time points.  
We also observed a differential response of NSCs, depending upon their 
embryonic time point, with regard to gliogenesis in response to vascular cell CM. 
At E11.5 there was an increase in Gfap expression in NB with Ezh2 inhibitor 
compared to NB media alone (no vascular CM) indicating that Ezh2-dependent 
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methylation may play a role in the repression of glial cell fate. The presence of 
vascular cell CM further increased this Gfap expression in the NSCs treated with 
both CM +/- Ezh2 inhibitor compared to complete NB +/- Ezh2 inhibitor. These 
results differed substantially with NSCs isolated at E13.5. In to E11.5 NSC, the 
E13.5 NSCs showed no significant difference in Gfap expression with Ezh2 
treatment suggesting that this late NSC time point is no longer sensitive to Ezh2 
inhibition or does not respond to PRC2 after initiation of vascular investment. 
These results indicate that there may be a difference in the NSCs competence, 
or their ability to respond to vascular cues, and that NSCs isolated earlier, prior to 
extensive vascular investment in vivo may be more apt to respond to the PRC2 
complex.  
Differences in glial gene expression based on the time point of NSC 
development have been previously demonstrated in in vivo studies of embryonic 
disruption examining the role of PRC2 in cortical cell fate decisions. Pereira et al. 
studied the role of Ezh2 prior to the onset of neurogenesis (E9.5) and found that 
when Ezh2 was deleted in vivo, Gfap expression occurred earlier in the cortex 
and Gfap-positive cells were more abundant at birth compared to wild-type 
littermates [27]. Hirabayshi and colleagues analyzed the role of Ezh2 in vivo at 
mid-gestational time point (E13.5 and E14.5) and found that knockout of Ezh2 
led to a reduction in the number of S100ß cells present just was reduced just 
after birth (P1.5) [28]. These results may suggest that the PRC2 (and Ezh2) have 
a different impact on cell fate correlated to the timing of cell fate decisions and 
the microenvironment context in which those cell fate changes occur. It would be 
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tantalizing to suggest that these differences resulting fromEzh2 knockout 
observed in vivo [27, 28] may be derived from the progression of vascular 
investment and the influence of vascular-derived signals on the NSC cell fate 
choice. One possible interpretation of the Pereira et al. study is that, in the 
absence of Ezh2 (and PRC2 trimethylation of H3K27) during the period of 
minimal vascular influence at early forebrain stages (prior to significant 
angiogenesis), the NSCs preferentially form glia at the expense of neurogenesis. 
The authors did not explore the role of the vasculature, or its potential disruption, 
in either of their knockout studies [27, 28], but this avenue would certainly merit 
further investigation. 
In the context of the effect of microenvironmental influences on 
gliogenesis, one of the most critical candidates discovered to date is the IL-6 
signaling pathway, of which Lif is a key player. Downstream of Lif signaling is 
Stat3, which is able to bind to the Gfap promoter to activate Gfap expression and 
induce gliogenesis [66]. Work by others has shown that Bone morphogenetic 
proteins (BMPs) treatment [59] or coculture models using adult and embryonic 
NSCs (E14.5) combined with endothelial cells are able to induce Gfap 
expression [60]. These BMPs are derived from endothelial cells [60, 67] and are 
thought to interact with Stat3 to induce gliogenesis [68].  
Our results indicate that the vasculature in the developing cortex does, 
indeed, provide soluble and contact-dependent factors that aid in the progression 
of NSC fate. This knowledge not only helps us to better understand normal 
development, but also that of disease states. In cases of neurodegenerative 
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disease, there is a population of glia cells that become activated or “reactive,” 
through a process is known as reactive gliosis (Reviewed in [130]). Recent 
findings have also implicated cortical vasculature in the onset and progression of 
these diseases (Reviewed in [111]). Perhaps the broader implication of this work 
is the utility of our heterotypic Transwell® coculture system as a useful tool in 
studying how vascular-derived signaling factors affect not only embryonic NSCs 
but also adult NSCs and glial in pathological conditions. 
 
Future Directions 
The goal of this research was to determine if and how vasculature 
influences neural stem cell fate decisions. While we determined that the 
vasculature does influence NSC fate decisions in our heterotypic coculture 
system, the specific mechanisms regulating this process bear further 
investigation. Possible future areas of research would be to identify specific 
components produced by the vascular cells, either released into the 
microenvironment as soluble signals or coordinated by direct cell-cell contact 
between the vascular cells and the developing NSCs. While we did identify that 
Lif was present in the coculture media, we do not know to what extent Lif affects 
NSC differentiation. Furthermore, other vascular-derived signals, such as BMPs 
may be driving this response in our coculture system. The addition of small 
molecule inhibitors that target either the Lif or BMP receptors on NSCs may 
provide one avenue to determine if Lif and/or BMP are mediating gliogenesis in 
our system or if there are other mechanisms involved.  
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The differences we saw in embryonic time point and response to both 
vascular-derived signals and Ezh2 inhibition also warrants further research 
regarding how cell competence may correlate the role of epigenetic regulation 
and the expression of genes associated with NSC fate choice. To better 
understand how microenvironmental signals regulate chromatin accessibility and 
the transcription of genes, techniques such as ChIP-seq and ChIP-qPCR could 
be used targeting H3K27me3 to determine which genes might be linked to this 
PRC2-mediated modification during NSC differentiation. The current working 
model entails the use of E11.5 and E13.5 as the embryonic time point source for 
our NSC. However, targeting cells from the primitive forebrain might help us to 
refine a sensitivity window for PRC2 action as well as allow us to distinguish 
between NSC competence during the period of active cortical angiogenesis 
relative to the primitive neuroepithelium at E9.5 prior to vascular investment in 
the cortex. 
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APPENDIX 
The Appendix contains supplementary results that were not presented within the 
body of the text. The data presented in this portion of the document were not 
required for data interpretation but are used to support the results and 
conclusions of the current study.  
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Table 1: Sequence for forward and reverse primers used for quantitative PCRs. Sequences are indicated 
5’→3’. 
          Alternative nomenclature          
Gene Name          or Acronym       
 
  
MS 18S           18S ribosomal       
 
  
  F:GACACGGACAGGATTGACAGATTGATAG         R: GTTAGCATGCCAGAGTCTCGTTCGTT 
                            
MS 18S Second Primer       18S ribosomal       
 
  
  F:TAACCCGTTCCCCATTC           R:CATCCAATCGGTAGTAGCGAC    
                            
 Glyceraldehyde 3-phosphate dehydrogenase    Gapdh       
 
  
  F: GTGGCAAAGTGGAGATGGTTGCC         R: GATGATGACCCGTTTGGCTCC   
                            
Hpoxanthine-guanine phosphoribosyltransferase  Hprt      
 F: TAAGCAGTACAGCCCCAAAT    R: AACGTGATTCAAATCCCTGAAG 
           
Paired box 6         Pax6       
 
  
  F: GCTTGGTGGTGTCTTTGTCA         R: TCACACAACCGTTGGATAC   
                            
 Glial fibrillary acidic protein     Gfap       
 
  
  F: TGCCTATAGACAGGAGGCA         R: GTTCTCGAACCTCCTCATAG   
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Table 2. cont.   Alternative 
nomenclature 
  
Gene Name    or Acronym      
Calbindin 1       Calb1       
 
  
  F: TGGATTGGAGCTATCACCGG         R: CTCGCAGGACTTCAGTTGC   
                            
Vimentin    Vim       
 F: CCAGAGAGAGGAAGCCGAAA    R: GTCAAGACGTGCCAGAGAAGC  
      
T-box protein 2/Eomesodermin   Tbr2/Eomes            
  F: GCAGGCGCATGTTTCCTTTC         R: GTGTTAGGAGATTCTGGGTGAACG 
                            
 Chemokine receptor 4       Cxcr4       
 
  
  F: TCCAACAAGGAACCCTGCTTC         R: TTGCCGACTATGCCAGTCAAG 
                            
Chemokine receptor 7       Cxcr7       
 
  
  F: AAGCCCTGAGGTCACTTGGTC         R:CAAACAAGTGCACATCCATGG   
                            
Chemokine ligand 12/ Stromal cell-derived factor 1  Cxcl12/Sdf-1       
 F: CCGCGCTCTGCATCAG     F: TGGCTCTCGAAGAACCGG 
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Figure 1: RNA-Seq dispersion plot. The dispersion estimates were plotted over 
the average expression strength for the 10 samples in the three coculture 
conditions (A). Maximum likelihood gene estimates were obtained using each 
individual genes data (black) while a curve (red) was fit to the data to capture the 
trend of dispersion-mean dependence. These values were then used as a mean 
to obtain the final maximum a posteriori, which reduces the noise of the 
maximum likelihood estimates towards the curve through shrinkage (blue). Black 
points circled in blue are considered outliers and are not shrunk towards the 
curve.  
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Figure 2: RNA-Seq sample clustering. To look at sample clustering, Euclidean 
distance was calculated using the regularized log (rlog) transformation from 
DESeq2. Hierarchical clustering can be seen on the top and left. Samples are 
indicated as numbered replicates for NSC in solo culture (Solo#), non-contacting 
vascular coculture (CC-N#), and contacting vascular coculture (CC-C#).
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Figure 3. Vascular cell influence on NSC methylation states. Ssea-1 enriched NSCs were cultured alone (Solo) and in 
the presence of non-contacting (CCN) and contacting (CCC) vascular cells in the Transwell® coculture system. Histone 
protein was extracted and 50 ng was used in a histone H3 modification assay (EpiGentek). Error bars indicate standard 
deviation and n=3-4 for each condition.
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